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ABSTRACT 
The aim of the work presented in this thesis is*to establish a 
mathematical model for use in the study of blood glucose dynamics and their 
disorders in man. 
A large number of models have been developed that represent various 
aspects of blood glucose dynamics and of these the majority have been attempts 
to provide a mathematical description of glucose tolerance test curves. Most 
of these models have no immediate clinical application and have also failed to 
provide arq real insight into the system that controls the flow of glucose 
into and from the blood glucose compartment. 
To do this a mathematical model must be formulated that approximates to an 
isomorphic description of the glucose regulatory system. Such a model must be 
based on sound biochemical and physiological knowledge. However, the complexity 
of the glucose system is such that complete simulation is not possible. 
In this study, a model has been developed and is described that places 
particular emphasis upon the role of the liver in controlling blood glucose 
dynamics. Compartments are provided for glucose, glucose-6-phosphate, and 
glycogen which are the dominant metabolic substrates. Mass balance equations 
have been written in terms of the enzymatic reactions that are involved in 
glucose transport and substrate kinetics. Insulin and glucagon hormonal 
controllers have also been incorporated. 
The model has been tested by inputs representing intravenous glucose 
infusion, intravenous glucose, insulin and glucagon injection. 
The model appears to simulate in general terms experimental data, and has 
yielded information about both the system structure and the enzyme dynamics 
involved. Of particular importance is the evidence that fine control of the 
glucose system is an intrinsic function of the enzyMe systems and that only 
coarse control of the system is provided by the hormonal environment. 
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Little work has been done in this field, but the present model is unlike 
any previous model in that the inherent non-linearities of the metabolic 
system are developed from known enzymological data. The approach illustrates 
the possible value of using kinetic data obtained from -in -vitro, 
experiments in 
predicting physiological changes within the in vivo system. 
It is considered that mathematical models of this type can provide the 
biomedical scientist with insight into the functioning of metabolic systems 
and highlight areas of weak knowledge. 
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CONVEIRIONS 
As far as has been possible the abbreviationsg conventions and 
symbols used in this thesis are those recommended by the Dditorial, 
Board of the Biochemical Journal in their Policy of the Journal and 
Instructions to Authors (Revised Version 1973)- 
References are given in the form used in the Biochemical Journal 
but with both the first and last page number being cited, together 
with the full title of the paper. 
At the first mention of an enzyme there is given the number 
assigned to it in &zyme Nomenclaturet Recommendations (1972) of the 
International Union of Pure and Applied Chemistry and the International 
Union of Biochemistry on the Nomenclature and Classification of Enzymos 
together with their Units and the Symbols of Enzyme Kinetics 
(Amsterdam : Elsevier Scientific Publishing Co., 1973)o 
Enzyme nudbere are given in the accepted form, EC 1.2-3-4. 
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1 see many biologists, like scientists in other 
fields, are too concerned with the discovery of 
experimental data, without being prepared to 
provide the necessary integrated theoretical 
background. It is one of the sad features of 
modern scientific development that theory is too 
often divorced from practice, an attitude that 
reflects against the belief, held by so many 
scientists, that science can develop by the 
accumulation of facts alone. ' 
(George, 1965) 
1 
'In a growing research discipline, inquiry is not 
directed towards re-arranging old facts and 
explanations * ... but rather to the discovery of 
now patterns of explanation*' 
(11anson, 1965) 
CHAPTER 
INMODUCTION 
I. The nature of the proble 
It has been known for more than fifty years that diabetes is 
characteristically associated with a decrease in glucose tolerance 
(ýanney and Isaacson 1918). An increase in the fasting blood glucose 
it; not invariable, and the most reliable laboratory procedure is the 
glucose tolerance test, which since its popularisation by Hamman and 
Hirschmann (1917) has become the most important test for the diagnosis 
of diabetes mellitus. Most practical for routine use and thus most 
commonly performed is the oral test. The intravenous test eliminates the 
problem of equivocal results due to defective alimentary absorption and 
allows calculation of the glucose "utilication. rate"O Nevertheless our 
knowledge of blood glucose dynamics is still mainly descriptive rather 
than explanatory. The distribution and disposition of glucose load and 
the maintenance of glucose homeostasia in the body are the results of a 
complex set of physiological processes and biochemical interactions. 
The readily observable dynamic events are the plasma, or blood, glucose 
concentration and its changes, and to a lesser extent the amount of 
glucose excreted in the urine. Consequently, the glucose tolerance 
test, in its oral or intravenous form, remains the most commonly used 
tool for the study of glucose metabolism in man, bothin clinical 
practice and in research. Recognising, the inadequacies of these tests 
as so often performed, there have been numerous attempts to introduce 
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standardised methods of performance and of interpretation (Joplin and 
Wright 1968). Nevertheless, the relationship between the conformation 
of the glucose tolerance curve and the mode of disposing of the glucose 
load is still poorly understood. This is probably due to the fact that 
this curve is the result of several metabolic processes and as such is 
unlikely to provide information about the dynamics involved. 
Some insight into the mechanisms which control blood glucose 
levels may be obtained by introducing theoretical modelso Several 
authors have used such an approach in an attempt to describe plasma 
glucose dynamics after the steady state has been disturbed by oral or 
intravenously injected glucose. 
Using information obtained from such experimental procedures, a 
formal compartmental model can be postulated and its parameters chosen 
according to statistical criteria to produce a "best" fit to the data. 
The weakness of this approach is that it is essentially an optimiciation 
procedure whereby a set of numerical values are found that give best 
fit of a predetermined model to experimental data. Its use has been 
critically reviewed by Atkins (1971). 
Such descriptions of the blood glucose regulating system do not 
givel furthermore, information about actual rates of utilisation and 
release of glucose from and into the blood, although some consider in a 
theoretical way the net changes of the amount of circulating glucose, 
which are due to differences between these rates. Yet it is by 
varying these rates that control mechanisms are able to maintain the 
circulating blood glucose within a normal optimal range in spite-of 
varying external factors such as fasting; or the ingestion or injection 
of glucose. Changes in the plasma or blood glucose concentration 
represent the integration over a time period of the differences between 
glucose utilisation and glucose release. This glucose concentration 
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is in itself an insensitive indicator of these values. But if 
information about glucose utilisation or release, whether in the steady- 
state or following glucose loading, is required, these rates must be 
calculated. 
In the final analysis the mechanisms by which all biological 
processes take place are chemical in nature and must be explained 
ultimately in the transformation of one chemical species into anothert 
with each transformation being catalysed by an enzyme. Therefore, it 
should be possible to describe the disposition of glucose in the body 
in dynamic terms using the linked reactions of the system for glucose 
metabolism. This system is an obvious candidate for the study of a 
problem in vivo, the sub-systems of which have been intensively studied 
in the varying tissues in vitro. 
The individual enzyme reactions are known, the substrates and 
coenzymes have been identified, the enzymes isolated and their 
properties studied. There is also significant information,, usually 
obtained in vitro,, as to how these reactions are controlled at the 
enzyme level. What is required is a model built to describe the 
system, then it should be theoretically possible to describe the 
#dividual Physiological processes and biochemical interactions in 
operational terms, and, if sufficient data are available, or obtainable, 
to predict those events that can be observed. Such dynamics are 
complex. and require a large number of parameters: often far more 
parameters are needed than can be-justified on the basis of a statis- 
tical-fit to plasma and excretion data. Generally, however, most of 
the parameters can be predicted within reasonable limits because much 
literature. exists which reports the quantitative behaviour of physiolo- 
gical systems. 
In fact', one of the primary experimental techniques for inferring ý 
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the behaviour of the processes within the body is to observe how the 
processes deal with an exogenous dose of glucose. The processes byý 
which glucose is distributed within the body are physiological and 
physicochemical. Much is known about these physiological processes, 
thus it is possible that such an approach will be rewarding because 
a) there is ý=ch information readily available in the literature; 
b) extrapolations may be attempted with some confidence if the 
mechanisms are understood; 
0) behaviour of the system may be predicted a priori; 
d) compartments correspond to anatomical spaces so that 
biochemical interactions can be incorporated. 
In fact, of recent years there have been attempts to bring Wstem 
theory into the quantitative study of physiological regulatory 
processes. 
The general philosophy of this approach, which has been called 
systems physiology, has been outlined by Mommaerts et al (1968). 
Briefly its objective is to determine the interconnections and couplingay 
within a system, and then model arA dynamically test the system. The 
goal is a mathematical model and/or computer model which couples the 
dynamics of each subEqstem and results in a faithful dynamic model of 
the overall system. The achievement of this goal provides more than 
a simulation of the system because it also provides information 
concerning the functional properties of the system. Information of 
this sort has immense practical implications for the diagnosis and 
treatment of metabolic disorders. 
II. The scope of the study 
The aim of the work presented in this thesis is, using the systems 
approach, to establish a mathematical model for use in the study of blood 
glucose dynamics and investigations of its disorders in mano 
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This is essentially a mechanistic model based on the unit processes 
of the system, that is the en2; 7me reactions. Little work has been done 
in this field* Models of the glycolytio pathways have been developed 
by the group associated with Chance and Garfinkel (see for review, 
Garfinkel 1969), but such an approach has not been attempted for the 
blood glucose regulatory system. 
The present study considers the glucose regulatory system in the 
context of a mathematical model based on the complex reaction system of 
the glucose metabolic network and involving the kinetics of the various 
enzyme and transport reactions. Thus in this model unlike any previous 
model the inherent non-linearities of the system are developed from 
known enzYMological data. This approach illustrates the value of 
using kinetic data obtained. in vitro in predicting physiological 
changes within the in vivo system. 
Pirstly, the whole concept of blood glucose dynamics is put into 
its historical perspective, with particular consideration being made of 
the role of the liver, and earlier attempts of modelling the system. 
Then, after a detailed exposition of the theoretical considerations 
involved, the development of the mathematical model is described. 
Evaluation of the model and the system by computer simulation is 
considered. The results section includes an appraisal of physiological 
data obtained from the procedures described, and finally the accept- 
ability of the method to clinical problems is discussed. 
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CHAWER 2 
A HISTORICAL ACCOUNr OF THE STUDY OF BLOOD GLUCOSE DYNAMICS 
Modern pl-, Qrsiological concepts of glucose metabolism and their 
relation to blood glucose dynamics have their origin in the studies 
of Claude Bernard. In 1848, Bernard demonstrated the existence of 
sugar in the blood of animals in the absence of prior carbohydrate 
feeding. In two healthy dogs sugar was present in blood taken from 
the heart after death. One dog had been fed on a meal which contained 
no starch; the other animal had received no food for two days* In 
subsequent experiments to determine the origin of the sugar Bernard 
placed ligatures at various places in the portal venous system 
immediately after death. No sugar was found in the blood coming from 
the spleen or pancreas; sugar was present in blood draining from the 
intestine, but the greatest quantity of sugar was found in the blood in 
the intrahepatic portions of the portal vein. Bernard concluded that 
the sugar originated in the liver. At that time he believed that the 
sugar from the liver was the same ail that of diabetes but that both 
differed from grape sugar; subsequently (1877) he acknowledged their 
identity. 
One of the most important results of the finding of glucose in the 
blood of fasting animals was the discovery of glycogen. By Bernard's 
own admission this was fortuitous. Normally duplicate estimations of 
the sugar content of liver'tissue were performed simultaneously but on 
one occasion, when pressed for time, one estimation was made immediately 
after the death of the animal and the other was delayed until. the 
following day. The second estimation gave a much higher result than 
the first. On investigating the discrepancy he found that the time 
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factor was of great importance in determining the amount of sugar present 
in the specimen., Only a small amount of glucose might be present soon 
after death but at the end of two hours a large amount of sugar had 
appeared. He perfused a still warm liver with cold water and freed the 
tissue of sugar. Subsequently large amounts of sugar appeared, proving 
that the sugar was formed from material in the liver tissue itself 
(Bernard 1855)- Bernard (1857) went on to isolate the sugar-forming 
substance, which he named 'glycogen', and described many of its chemical 
and pbysical properties. Sanson (1857) found that muscle tissue also 
contained a considerable amount of glycogen* 
Young (1937) Pointed out that Bernard's early theories on the fate 
of the sugar liberated by the liver 'were erroneous* Bernard believed 
that the sugar diffused over the organism by way of the circulation and 
that the amount steadily diminished with the distance of the blood from 
the liver (Bernard 1855, b). Por mar7 years Bernard also insisted that 
the portal blood of a dog fed only on meat did not contain sugar. 
Several investigators disagreed strongly with him on this point. 
Piguier (1855) found sugar in the portal vein of a dog two and a half 
hours after ingestibb-.,. of meat but found no glucose in the portal 
blood of an animal which had been starved of foods Chaveau (1856) 
conducted a careful study of the concentration of sugar in a variety of 
vessels; he found it in the portal vein and in the blood draining the 
small intestine in animals fasted for forty-eight hours. Under 
conditions of fasting or meat feeding the concentration of sugar was 
always higher in the hepatic veins than in any other vessel including 
the portal-vein. Chaveau also found that the concentration of sugar 
wan the same on the two sides of the heart and in all the arteries, but 
there was constantly more sugar present in arterial blood than in venous 
blood. 
Pavy (1860) also found sugar in the portal blood in amounts similar 
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to those found under normal circumstances in the heart and other vessels 
of the body. When blood was taken from the heart during life only a 
trace of sugar was detected but large amounts were found shortly after 
the death of the animal. Pavy also showed that respiratory obstruction 
(Bernard 1855) or struggling (Pavy 1860) caused an unnatural increase of 
the sugar in the circulation. 
Studies on the relative amounts of sugar in different vessels set 
the scene for the investigation of the fate of ingested glucoseo This 
problem was the starting point of Bernard's investigations. His "aim 
was to follow closely the sugar which was absorbed from the food in its 
passage along the blood stream, first to the liver, then to the lungs, 
and finally to-all the other tissues in the body. I wanted to know if 
the sugar was destroyed in traversing the liver, which is the first 
organ through which it passes after being absorbed into the tributaries 
0f the portal vein" (Bernard 1853)- 
Bernard's own views on the fate of absorbed sugar were contradic- 
tory. In 1877 he wrote "The liver acts upon and transforms any sugar 
which appears, directly or indirectly, as a result of the absorption 
of food. The sugar disappears in its passage across the glandq while 
glycogen appears.. " This suggests that Bernard believed that the liver 
blocked the passage of sugar through it; a view was apparently confirmed 
by his observation that if a given quantity of glucose was injected into 
the jugular vein of a dog it passed more readily into the urine than if 
the same quantity of glucose was injected into a branch of the portal 
vein. Bernard further showed that feeding of potatoes to a dog with 
an obstruction of the portal vein resulted in a definite glycosuria and 
quoted as clinical confirmation the presence of diabetes in a subject 
with portal vein obstruction and alimentary glycosuria in cirrhotics 
with portal vein obliteration. 
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However in the same book he wrote "In the liver sugar it; produced 
although a little is also destroyed in that organ; in the muscles sugar 
is destroyed. Destruction of sugar probably occurs throughout the 
organism, in all organs, in all the tissues. ', He thus recognised that 
other tissues could utilize glucose; indeed some of his researches led 
him to question the role of dietary sugar in the production of hepatic 
glycogen* In 1858 (Bernard 1877) he performed experiments indicating 
'that the liver of a dog fed on starch contained less glycogen than that 
of a dog fed on fibrin; other experiments led him to believe that glucose, 
sugar and starch were not able to give rise to liver glycogen in fasting 
animals to which these foods alone were given. He concluded that cane 
sugar, and probably the other carbohydrates, were 'nutritive stimulators, 
of glycogen formation but that they were not directly converted to 
glycogeno Bernard wrote that nitrogenous matter was the chief source of 
the glycogen manufactured by the liver. 
Pavy had a different concept of the fate of ingested glucose arA the 
role of the liver. He found in 1858 that the total amount of glycogen 
in the liver of sugar fed animals was much greater than that to be found 
in the liver of animals receiving other types of food. He therefore 
considered that liver glycogen might be formed from the sugar in food. 
In 1862 he found that the blood flowing from the liver of an animal which 
was digesting carbohydrate had a smaller concentration of sugar, than was 
to be found; on the average, in the blood of the portal vein under- 
similar circumstances. This indicated that the liver was absorbing the 
ingested sugar (see Young 1937), 
Pavy (1894) believed that the circulating blood contained a standard 
amount of glucose which presented no essential variation in the different 
Parts of the system. This normal stability of the blood sugar level and 
the serious nature of the disease diabetes, in which there was a high 
blood sugar, led Pavy to suggest that 
ýiucose 
was toxic, in the body and 
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that the liver protected the organism by converting the sugar to 
glycogen. 
The main problem in all the studies performed up to this time was 
the lack of a reliable method for the measurement of blood sugar in 
small amounts of bloodo Serial estimates could not be performed and it 
was impossible to. follow with any accuracy changes in the eoncdntfation., of blood 
glucose in response to glucose loadingo 
The prime stimulus. for research into carbohydrate metabolism in man 
was the prevalence and serious nature of diabetes mellitus. Apart from 
its clinical characteristics the main diagnostic feature of the disease 
was glycosuria. This was usually detected by testing for reducing 
substances and the presence of glucose itself was occasionally confirmed 
by the demonstration of fermentation, dextrorotation of the plane of 
polarised light and osazone formation. Normal human beings and animals 
were found to have small amounts of reducing substance in the urine* 
This was assumed to be an indication of the presence of glucose or 
another sugar in the urine, 
The recognition that significant glycosuria could be caused, under 
certain circumstances, by the administration of sugars to normal humans 
arA animals stimulated interest in the quantitative relationship 
between glycosuria and the diaWtic state. The concept of 'carbohydrate 
tolerance' originated at this time. According to Polin and Berglund 
(1922) this term originally represented the amount of carbohydrate which 
a diabetic patient could take in the course of twenty-four hours'without 
the appearance of sugar in the urine. A different meaning was used 
after Hofmeister (1888-9) introduced the term 'limit of sugar assimilation' 
to indicate the amount of sugar which could be taken in one dose to 
without any demonstrable loss of sugar in the urine* It was'to-this form 
of measurement that Allen (1913) referred when he' wrote': I'Tesýs'of 
'sugar 
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tolerance may be oral, subcutaneous, or intravenous. Each may possess 
some advantages. The oral method holds its clinical position by reason 
of its convenience; it is open-to error through irregularities of 
ibsorption and the role of the, liver is important, especially in the 
case of laevulosee The intravenous test is perhaps the least useful; 
it is merely a kind of saturation limit, representing the amount-of 
sugar the tissues and fluids can hold without, overflowing the kidneys; 
undue importance may thus attach to slight variations of renal 
permeability; especially the test does not determine the-ability of the 
tissues to withdraw sugar from the blood* The subcutaneous method is 
the best test of the power of the body-tissues to utilize sugar-" 
Folin and Berglund (1922) pointed out that the original concept of 
alimentary glycosuria (or glycosuria induced by other routes of sugar 
administration) "implied the false assumption that the taking of a 
larger dose of sugar than that just sufficient to produce some 
glycosuria meant that all the surplus sugar taken would pass into the 
urine. The e3ýroneous nature ofAhis assumption was pointed out by 
Unossier and Rogue (1895) who expressed the fact that the 
more sugar that is taken the more is retained and utilized by non- 
diabetic individuals.,, However the inadequacy of this concept was 
demonstrated by Pavy and Godden (1911) who showed that when intravenous 
glucose was given the production of glycosuria depended more on the 
rapidity of the administration than on the dose given. 
The relationship between the height of the blood sugar and the 
presence of glycosuria had been recognised by Bernard and Pavy but later 
workers established the relationship more clearly. However the blood 
sugar level was not the only factor determining glycosUria. In 1913 
Allen wrote "The relative permeability of the kidneys-for sugar is a 
factor, sometimes an important factor, in determining the presence or 
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absence of glycosuria under a wide variety of conditions* The renal 
factor, like the other factors governing glycosuria; may produce effects 
in either direction, either towards causing glycosuria or towards 
preventing it. " 
The measurement of glucose tolerance by assessment of glycosuris, 
was always of doubtful significance due to the variables involved. In 
particular there was considerable argument as to whether or not glucose 
was present in normal urine while those who claimed that glucose was 
present were unable to agree on the amount which should be considered as 
normal. 
The need for a reasonably accurate micro-method of measuring blood 
sugar was first met by Bang (1913) with his iodide-reduction method. 
Numerous other workers subsequently presented new methods of increasing 
sensitivity and accuracy (see Henry 1960 for a review of methods). so 
gradually the assessment of carbohydrate tolerance was determined not by 
the presence or absence of glycosuria but by the height of the blood 
sugar rise following the administration of oral glucose. 
Jacobsen (1913) used Bang's method to show that after ingestion of 
100g glucose an appreciable rise in the blood sugar occurred, in a 
normal subject' withih five minutes: the maximum level was usually 
attained in about thirty minutes, and a return to pre-ingestion levels 
occurred within an hour and three quarters. He tested several 
diabetics with 509 of bread and showed that the actual rise of the blood 
sugar was not great but that the fall was slow. The paper of Hamman 
and Hirschman (1917) really popularised the tolerance test and -, 
subsequently the changes in blood level after oral glucose administration 
'were widely used by clinicians, and in experimental studies in animals 
and man as an index of the efficiency of blood, sugar regulatory mechanisms. 
The early work was reviewed by Maclean and de Wesselow (1921) and Hale- 
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White and Payne (1926) and more critical reviews have been presented by 
Baird and Duncan (1959). Roockel (1971) and De La Huerga and Sherrick (1970- 
A variety of tests have been employed using varying amounts of glucose 
in an attempt to make interpretation of the test more reliable. In this 
country the British Diabetic Association recommend that 50g of glucose be 
administered to a subject who has been fasting overnight, whilst in the 
United States it is the usual practice to administer 100g. Intermediate 
doses such as 759, or doses proportional to body weight, ouch as one or 
1-759 per kg body weight have been used. In 1969 th4 American Diabetic 
Association recommended a dose of 40g per square metro of body surface. 
The blood glucose is determined usually on venous blood obtained before 
glucose loading and then at timed intervals after glucose ingestion. The 
intervals are usually every 30 minutes for a period of 2-3 hours- Urine is 
sometimes collected at intervals similar to a crude method of assessment of 
the renal threshold for glucose. Other difficulties have arisen in attempts 
to standardise the test, for accurate comparisozis are almost impossible as 
different glucose loads have been used, and capillary, venous blood or plasma 
analysed by numerous analytical methods. 
Furthermore, it has become increasingly apparent that intolerance of 
glucose is not an exclusive feature of clinical diabetes mellitus, but may 
be the result of very many-phyeiological and pathological changes* 
Little work has been doteýon the physiological mechanisms responsible 
for the shape of the oral glucose tolerance test curve. Two of the 
factors 'which have been accorded great importance are the rate of gastric 
emptying and the rate of intestinal absorption of glucose. Bailey 
(1919) wrote "An important observation of all of these tests Is the 
ma. rked disproportion between the greatest blood cilgar concentration and 
the amount of sugar ingested, allowances being made for differences in ,-- 
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body weight. This disproportion is seen in the work of individual 
authors and makes one think that sugar tolerance tests based on blood 
sugar estimations are really tests of intestinal absorption-", Hale- 
White and Payne (1926), however, pointed out that the rate of gastric 
emptying seemed to have no effect on the ascending limb of the curve 
as this was similar in subjects given oral glucose and in three subjects 
given glucose directly into the duodenum. They also showed that the 
blood sugar could return to normal while glucose was still present in 
the stomach and that it could start falling while a considerable amount 
of glucose was present in the stomach# 
The role of the liver in handling glucose absorbed from the 
intestine has been emphasised since the early work of Bernard and Pavy. 
The importance of the peripheral tissues was not fully appreciated until 
large arterio-venous glucose differences were demonstrated after oral 
glucose loading (Foster 1923)- So"magyi (1948) investigated this problem 
extensively; he pointed out that arterio-venous'differences were very 
small in pancreatectomized animals but that they increased considerably 
after the injection of insulin* An increase in arterio-venous differ- 
ences occurred in normal subjects during alimentary hyperglycaemia; this 
was attributed to an increased supply of insulin from the islets. 
S*oOm5gyi emphasised the role of the extrahepatic tissues and suggested 
that during an alimentary hyper-glycaemia the muscles remove, more glucose 
from the blood than Oes--the. -liver. 
Soskin and his colleagues (1934) questioned whether augmented 
insulin secretion following oral glucose was responsible for the shape 
of a normal glucose tolerance curve. They infused insulin at a 
constant rate into pancreatectomized dogs and by this means kept the 
blood sugar constant. They found that injection of glucose into these 
animals resulted in normal 'glucose tolerance curves'. It appeared 
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that provided sufficient insulin was present to maintain a constant 
blood sugar level, no additional secretion was necessary for adequate 
regulation. When normal dogs were hepatectomized, however, and a 
constant amount Of glucose given to maintain a normal constant blood 
sugar level, the administration of glucose led to markedly 'diabetic, 
curves. This occurred in the presence of a normal pancreas. These 
findings suggested to Soskin and co-workers that the pancreas was not 
essential to the regulating mechanisms responsible for the normal 
glucose tolerance curve while the presence of the liver was essential, 
However the importance of the liver may not have been due to its capacity 
for glucose uptake as Lang, Goldstein and Levine (1954) demonstrated that 
the presence of the liver was necessary for efficient utilisation by the 
peripheral tissues. 
Most of these studies were done before methods were available for 
the measurement of insulin in blood. In 1950(a) Bornstein demonstrated 
that following subcutaneous injection of insulin in alloxan-diabetic, 
hypophysectomized, adrenalectomized rats the fall of blood sugar 
correlated well with the amount of insulin administered. He used this 
preparation to assay linsulint in human plasma (Bornstein 1950b). 
Following the administration of 509 of glucose orally the plasma 'insulin' 
concentration increased as the blood sugar rose but its peak did not 
reach a maximum until two and a half hours after the ingestion of 
glucose - well after the peak of the glucose curve. This effect of oral 
glucose on the plasma insulin level was subsequently confirmed by 
biological assay of 'insulin activity' on the rat diaphragm (Vallance- 
Owen and Hurlock 1954) and on the tissue of the rat epididymal. fat pad 
(Samaan, Fraser and Dempster 1963). 
These methods of insulin assay depended on the measurement of 
biological effects which could have been affected by inhibitors of 
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insulin, by substances having the same action, or by factors potentiating 
the response to insulin itself. In 1959 Yalow and Berson introduced a 
radioimmuno. assay method for plasma insulin of great sensitivity. 
These workers confirmed a finding which had been obtained'with biological 
assays that insulin levels rise sharply after oral glucose. 
The oral glucose tolerance test has retained its popularity, The 
vagaries of gastric emptying and intestinal absorption, howeverg led 
many workers to advocate the use of intravenous administration of 
glucose for assessment of the capacity of the body to assimilate glucose. 
Intravenous sugar was used when glycosuria, was the only method of 
assessing tolerance-but was foundlatithat time to be unsatisfactory as 
tolerance depended less on the does of glucose which was given than on 
the rate of administration. When repeated blood sugar determinations 
became possible the response'of the blood sugar level to intravenous 
glucose administration became a practical method of assessing glucose 
tolerance. But, as with the oral test little experimental-work has 
been done on the Physiological significance of the intravenous tolerance 
test* Most authors have agreed that following the intravenous injection 
of glucose there is an immediate rise in the blood level; this 
initially falls rapidly as the result of diffusion thrbughout the 
extracellular fluid together with the loss of a small amount into the 
urine. When this rapid equilibration has occurred the rate, of 
disappearance from the blood is thought to-reflect the not metabolic 
removal of glucose by the tissues. 
Tunbridge and Allibone (1940) reviewed early studies and pointed 
out the confusion which arose owing to the varying strengths and amounts 
of glucose solution used and the varying time taken for injection. In 
1913 Thamhauser and Pfitzer injected 359 of glucose over a period of 
fifteen minutes and found that in normal subjects and those with mild 
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diabetes the blood sugar fell rapidly to pre-injection values while in 
subjects with liver disease and more severe diabetes it took a much 
longer time before the excess of sugar was eliminated from the blood. 
Jurgensen and Plum (1923) gave 20g of glucose by rapid intravenous 
injection and found in normal subjects a rapid fall in blood sugar 
concentration which dropped below pre-injection values. In diabetics 
they also found a very rapid initial fall but the curves later became 
progressively less steep causing the area under the-curve to increase. 
The intravenous glucose tolerance test using a single bolus load 
has been widely used for marV years. The rapid injection method of 
assessing intravenous tolerance is the one that has been most generally 
accepted. Even so there is little uniformity of procedure, particularly 
with respect to the dose of glucose injected, and there has been 
considerable lack of agreement as to the beat method of evaluating the 
results obtained. Jurgensen and Plum (1923) used the area of the 
curve and the time taken for the blood sugar level to return to pro- 
injection values, Crawford (1938) used the time taken to reach the 
value of 100 mg/100 mi, while Lozner and his colleagues (1941) used the 
two hour blood sugar value as their index. 
The principal advantages of this test over oral glucose tolerance 
tests are that it eliminates the problem of variable intestinal 
absorption and gives a quantitative index of carbohydrate utilization 
by allowing calculation of the specific rate constant k from a 
glucose-time relationship; k has commonly been derived from the 
exponential equation originally introduced by Hamilton and Stein (1942): 
CG =c0 4-kt 
where CG is the blood glucose concentration at any time t and C0 
the concentration at time zero. 
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This equation would be justified if a logarithmic plot of glucose 
concentrations as a function of time were to produce a straight line. 
If the slope of the glucose curve is plotted against the corresponding 
glucose values a linear relationship with a positive intercept implies 
that a constant term is present in the equation (Figure 1). This 
constant is equal neither to zero nor to the fasting glucose concentra, 
tion, and is the asymptotic value of the decay curve (C M) 
(Greville 
1943, Mad, Elrick and Arai 1959)- Thus the above equation can be 
rewritten: 
cG m (CO _ CEQ) jkt +C 
- 
RO 
- 
The glucose Plot fits closely to this equation up to 90 minutes after 
injection of the glucose. This expression is consistent with a constant 
rate of glucose input, reflected by the term C EQ 9 and an exponential 
decay in the rate of dissimilation, characterised by the term -k . 
However, Conard and his colleagues (1953) and Ikkos and Luft (1957) 
reverted to the simpler met6d of Hamilton and Stein and plotted 
graphically on semi-logarithmic paper the total blood glucose concentra- 
tion against time. They called the slope of the straight line which 
best fitted their experimental data the 'glucose assimilation coefficient, - 
This method is probably the most widely used today for the assessment of 
intravenous glucose toleranceg a constant, k, being used to describe 
the rate of disappearance of glucose* k is calculated simply from the 
equation: 
k 0.693 ti 
where t& is the time required for the level of glucose excess to be 
reduced by one half its value. 
The derivation of this expression is as follows: 
The half-life period (tJ) of a substance is the time taken for the 
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concentration of the substance to decrease by one half. ' 
For a first-order reaction the kinetic equation is 
log a kt -Z: x- m -2-303 
substituting tj for t and ja for both x and (a-x) the relationship 
'between the value to t; j aril the initial conMIATO-tiOll 
A-1a 
2-303 
-- k log - Fa- 
in 
Transposing k= 
2.303 log 2 
k 
0.693 
k 
Cramp, Oakley and Johnson (1971) calculated the terms k and C EQ 
from original intravenous test data using a curve fitting computer 
programme (Figure 2(a)). The principle of the procedure was that 
glucose values and their times of measurement were read into the 
computer (Figure 2(b)) and an initial set of values for C EQ and k 
calculated (Figure 3(a)). These values were then improved upon by 
an iterative technique until the difference between successive 
approximations is very small. 
Validation of goodness of fit of predicted curves was assessed on ten 
randomly selected intravenous tests in two ways; the mean percentage 
divergence over all points from 10-90 minutes for these tests is 2*2% 
(range 0.6 - 4-7), while the mean percentage of divergence at any point 
in time through the ten tests was 2. C% (range 1.1 - 3-5)- 
The Greville equation seems to be the best to describe blood glucose 
disappearance (Figure 3 (b)). Abnormality in glucose tolerance may be 
characterised by deviations from the normal of either or both k and C,, o 
a- 
Figure 2(a) 
Algorithm of curve fitting program. 
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SUB 202 A 
*** RESULT AFTER 10 ITERATIONS v ESQUARED 9597991 
INITIAL CORRECTED DIFFERENCE 
300 296*436 3*56408 
225 2329429 -7*42932 
186 185*909 9*05151E-02 
, 155 1520099 2,190106 130 127*525 2947451 
112 109*665 2*33441 
95 96o635 -1*68502 
85 67*2508 -2*25076 
202 B 
*** RESULT AFTER 10 ITERATIONS a ESQUARED = 24*5456 
INITIAL CORRECTED DI FFERENCE 
285 282*923 2907714 
245 247*147 -2914715 
213 215*935 -2*93548 
190 188*705 1929437 
167 164*949 2*05041 
145 144*224 e775878 
126 1260142 -*1427 
110 1109368 -*368041 
96 9696057 -*605743 
Figure_2(b) 
Facsimile of curve fitting print-out. 
I 
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-ft ----------------------- ; -------------- wm --------------- 
mm 
NAME 
-3919107 
-1936476 
-24,26953 
-2o27587 
-4*0634 
-3*75166 
-208314 
-2o86463 
-1000816 
-1*66967 
-2*77772 
-1,37892 
-3*69444 
-3e54372 
CF ERROR 
m ----------- mm m-m m ---------------------- 
SUB 202 A 
202 B 
203 A 
203 B 
204 A 
204 B 
205 A 
205 B 
206 A 
206 B 
207 A 
207 B 
208 A 
208 B 
70 
60 
50 
90 
lolapl. 
Wo 
10 
KxIOO 
30 
20 
10 
0 
CEQ 
6291529 
2*49078 
7697344 
52*5674 
39*2109 
34o692 
52,6671 
4995854 
-16*3673 
71*4713 
504,7577 
-2*14378 
2795788 
5798894 
Co 
3849502 
323e93 
3600218 
39 6* 698 
388*409 
493*051 
294*456 
351*732 
257*582 
. 334*356 343e83 
29 7* 608 
392*151 
393935 
Figure 3(a) 
Cumulative print-out of derived f=ctions. 
K 
a ........... 
8 ........... 0 ..... 
..... W 
*a ............ 
w .. 
10 20 30 
e 
40 50 
Ceq 
Pigure 3(b) 
computed 
: 
best fit 
. 1"" 
EPL. GL. 
=93mg/100m1 
- computed 
I best 90 pl. 91. 
1 01 
60 70 80 90 100 
84 9 5* 799 1ý', 
83 24*5456 
80 66*6595 
77 39*4103 
71 9399039, 
72 12*6944 
72 98o159 
76 74*8244 
75 12o7534 
91 125-977, 
75 89*7447 
73 86oSI93 
so 8901665 
89 129o469 
Graph confirming validity of method. 
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I feel that the introduction of the parameter C EQ destroys the simple 
concept of diabetes being characterised by low k values, in that some 
clearly abnormal intravenous testis are best described by high values of 
both k and C EQ " This implies normal assimilation of glucose 
in the 
presence of increased mobilisation. This concept may be a useful basis 
for further studies on the abnormalities of carbohydrate tolerance in 
various types of diabetes. 
Indeed it seems possible in ignoring the constant term C EQ in the 
first order equation or equating it with the fasting glucose value one 
may be overlooking a physiologically significant parameter, which could 
possibly be related to glucose output from the liver independent of an 
uptake which is proportional to blood glucose concentration. 
Franckson and him colleagues (1962) demonstrated that following 
intravenous glucose there was a reversal of the normal hepatic-balance 
and glucose was taken up by the liver. The role of the other tissues 
in assimilating the injected glucose has received little attentionO 
Franckson et al. pointed out that since the speed of assimilation appears 
to remain constant (in that the plot of log glucose against time gives a 
straight line), the serum insulin activity should not show marked 
variations during this exponential phase. They studied the insulin 
response to intravenous loading, using a rat epididymal fat pad method 
of measuring insulin-like activity; they found "a transient increase in 
insulin-like activity, of only slight importance. " 
Many workers had observed that plasma insulin rises after intravenous 
glucose and Samols (1965) showed that the rate of disappearance of glucose 
from the blood following intravenous injection appear6d to correlate with 
the initial plasma insulin response and claimed that the insulin response 
to injected glucose was important in determining the rate of glucose 
disappearance. 
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There has been much debate over the relative advantages and dis- 
advantages of oral and intravenous glucose tolerance tests 
(see Duffy, 
Phillips and Pellegrin 1973, for a good review). In favour of the oral 
test is the fact that it is easy to perform and most workers have an 
idea of what they consider to be a normal response. However variations 
in gastric emptying and intestinal absorption are unpredictable and 
uncontrollable* Gastrointestinal disease may either flatten the curve, 
as in some malabeorption states, or increase the height of the curve, as 
with the rapid gastric emptying following gastrectomy. Furthermore the 
rising and falling limbs of the oral curve do not reflect the true rates 
either of absorption of glucose or its disposal since the two processes 
are coincident over much of the curve (Duncan 1956). 
The main advantage of the rapid intravenous glucose tolerance test 
is that an accurately measured load of glucose is administered in a known 
time. The recult can be expressed fairly precisely in a form which 
allows a comparison of tests performed under different circumstances& 
Such a comparison is aided by the fact that the results of duplicate 
tests in the same individual under standard conditions show no significant 
difference on the two occasions (Duncan 1956). The main disadvantage of 
the intravenous test is that concentrated glucose has to be injected; this 
renders it less suitable for children and local leakage and mild plebitis 
may occasionally occur* When one compares the pros and cons of the two 
methods, oral and intravenous, it is easy to sympathise with Duncan (1956) 
who wrote "it is surprising indeed that the relatively crude oral test is 
so commonly employed when a much more accurate index of glucose tolerance 
is desirable. " 
However, the assumption that has been made, and still in, made in 
studies comparing the oral and intravenous methods of testing glucose 
tolerance is that they stress the same mechanisms of glucose assimilation 
and that there is no profound difference in the metabolism of glucose 
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administered by one or other route. Discrepancies between the tests 
have usually been attributed to the effects of gastric emptying or 
intestinal absorption. It has, however, been suggested . 
(MoIntyre at al. 1970) 
that the anatomical situation of the liver is important in the modifica- 
tion of the response to oral glucose. 
This study is a detailed consideration of a mathematical model 
that may yield information about the differences-which exist between 
the responses to oral and intravenous glucose and the mechanisms which 
may be responsible for these differences* However, before description 
of such a model further consideration will be given to the biochemical 
mechanisms that could be involved in the hepatic regulation of blood 
glucose concentrations. 
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CHAPTER 
THE BIOCHEMICAL MECHANISMS INVOLVED IN THE COIMOL OF GLUCOSE 
UPTAKE AND RELEASE BY THE LIVER 
As discussed in the last chapter the capacity of the liver to 
maintain the blood glucose concentration at an optimal level when the 
dietary carbohydrate intake is low was first recognised by Claude 
Bernard. 
However, the first detailed biochemical experiments on blood 
glucose regulation by the liver were performed by Soskin et al. (1938) 
who demonstrated that the dog liverv in situ, would take up glucose 
when perfused with hyperglycaemic blood, and would release glucose when 
the glucose concentration of the perfusate was low* 
Brady, James and Farrar (1949) confirmed these observationsg 
using catheterisation techniques, as did Searle and Chaikoff (1952), 
who used an isotopic technique to estimate glucose production, and 
showed that hyperglycaemia inhibited hepatic glucose release. Cahill 
et al. (1959) proposed that the balance between hepatic glucose uptake 
and hepatic glucose release was primarily determined by the relative 
activities of hexokinase (EC 2-7-1.12) and glucose-6-phosphatase 
(EC 3.1-3-9)- Of the two enzymatic activities hexokinase would 
probably be more responsive to changes in glucose concentration in the 
blood. 
Subsequent studies by Herrera et al. (1966) have suggested that in 
the isolated perfused liver the rate of incorporation of carbon atoms 
from alanine into glucose can be significantly altered by the glucose 
concentration of the perfusion medium. Exton and Park (1967) on the 
other hand did not observe any marked effect of perfusate glucose 
concentrations on the incorporation of carbon from lactic acid into 
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glucose in the isolated perfused rat liver. 
To explain the physiological functioning of the liver in bio- 
chemical terms it is necessary to- identify the reactions that can be 
described as regulatory as far as hepatic glucose release and uptake 
are concerned. 
It is improbable that transport across the hepatic cell membrane 
is regulatory for transfer of glucose across the membrane is an 
equilibrium. process. This is demonstrated by the fact that the membrane 
is highly permeable, the intracellular concentration is similar to the 
extracellular concentration, and that extracellular 
1 tqglucose 
rapidly 
equilibrates with intracellular glucose independent of the direction 
glucose flux. 
The obvious candidates for regulatory control areg as pointed out 
by Cahill et al. (1959), hexokinase, the enzyme that phosphorylates 
glucose, and glucose-6-phosphatase, the enzyme that hydrolyses glucose-6- 
phosphate to yield glucose. Both enzymes catalyse non-equilibrium 
reactions; the mass action ratios for these reactions are smaller than 
the equilibrium constants and the maximal catalytic activities of these 
enzymes are low compared with the other enzymes of the glycolytic pathway 
(see Table I). 
Glucose uptake by the liver 
The phosphorylation of glucose may be catalysed by one of several 
enzyme systems (Cahill, et alo 1959), classified by Katzen (1967) 
according to their Km. for glucose, as type (1) Km 1075m; type (2) Km 10 -4 
,IIII 
type (3) Km 107 
6 
and type (4) Km Cr-2 hexokinaseO' The enzymes with the 
low Km types, 1 to 3, are fully saturated at very low plasma glucose 
concentrations* Type 4 exhibits JV max with a plasma glucose 
concentration of 10 mmol, which would permit an increased hepatic 
glucose uptake with an increasing hepatic portal blood glucose concentra- 
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Enzyme Enzyme activity in Amo /min/g 
0 
fresh weight at 37 C 
Hexokinase 0-5 
Glucokinase & 2.0 
Glucose-6-phosphatase 12 
Glucosisomerase 280 
6-phosphofructokinase 5-0 
Hexose-diphosphatase 20 
Fructose biphosphate aldolase 6.2 
Glyceraldehyde phosphate 
dehydrogenase 150 
3-phosphoglycerate kinase 130 
Enolase 53 
Pyruvate kinase 37 
Lactate dehydrogenase 230 
Pyruvate carboxylase 8-3 
Phosphoenolpyruvate 
carboxykinase 13 
,k 
Table I Maximal activities-of. the glycolytic and gluconeogenetic 
enzymes in the hepatocyte. Data from Scrutton and Utter 
(1968)ý 
37 
tion over a wide physiological range. It is the differences between the 
properties of this latter enzyme, glucokinase (EC 2-7-1-12), and the other 
hexokinases that provide the basis of a theory of regulation uptake which 
is consistent with the physiological function of the liver. After a meal 
containing carbohydrate the concentration in the portal blood increases from 
about 5mmol/l to 12mmol/1 or more and becaWse glucose transport is an 
equilibrium process the intracellular glucose rises in parallel. This 
increase in concentration of glucose produces a marked rise in glucokinase 
activity and hence of hepatic glucose uptake. The high Km of glucokinase 
for glucose is necessary for operation of this control step, for hexckinase 
would be saturated at 1mmol/1 glucose and any change above that concentration 
would have no effect upon its activity# Also the absence of product 
inhibition of glucokinase ensures that hepatic accumulation of glucose-6- 
phosphate does not interfere with glucose uptake. 
Stimulation of glucokinase activity thus leads to an increased 
concentration of hepatic hexose phosphatesq which in turn leads to an 
increase in activity of 6-phosphofructokinase (EC 2 7-1-11) and UDPG 
glUcosYltransferase (EC 2.4-1.1l)- Thus increase in glucokinase activity 
will provide a control system in which increase in hepatic portal glucose 
concentration increases hepatic uptake and stimulates glycolysis and 
glycogen synthesis. 
Thus, hepatic glucokinase can be seen to be a mechanism that by-passes 
the regulation of glycolysis as seen in muscle, in which product inhibition 
of hexckinase has a dominant role. The importance of this mechanism is 
great in that it permits the liver to regulate glucose uptake depending 
upon the hepatic concentration of glucose, and also facilitates the 
corrversion of glucose residues to glycogen or/and triglyceride (see 
Figure 
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. Evidence for the involvement of glucokinase in this fashion is as 
f ollows: 
i) glucokinase is found in liver tissue only, and furthermore liver 
is the only tissue subjected to large variations in extracellular 
glucose concentration because of its proximity to the absorptive area 
of the gut; 
ii) the activity of gluackinase varies markedly with the dietary state, 
and these changes appear to be due to changes in concentration of 
I 
enzyme-protein probably controlled by insulin (Walker 1966). 
There is no doubt that the enzyme activity increases under 
conditions when the plasma insulin is high, as after feeding, and 
decreases when the plasma insulin level is low as in starvation or in 
diabetes mellitus. 
Sharma, Manjeshwar and Weinhouse (1964) and Katzen (1967) have 
demonstrated reduced activity in starvation, and Borrobask et al. (1970) 
the similar effect of low-carbobydrate diet* Several hours after re- 
feeding with carbohydrate following carbohydrate deprivation, 
glucokinase activity increases to normal levels (Borrobaek et al. 1970; 
Salas, Vinuela and Sols 1963)- Furthermore, Hornichter and Brown 
(1969) demonstrated that following starvation there is a direct 
relationship between hepatic glucokinase activity and glucose tolerance. 
McCraw (1968) has also shown that in the isolated perfused rat 
liver glucose utilisation is reduced following starvation, whilst 
Landau, Leonards and Barry (1961) have demonstrated that in the dog 
sensitivity of the liver to changes in blood glucoselconcentration is 
considerably decreased by prior carbohydrate restriction. Furthermore, 
during glucose infusion in animals on a high carbohydrate diet blood. 
glucose levels increased very little only reaching 100-130 mg/100 ml 
yet net hepatic glucose storage (as glycogen) occurred; 'in contrast, 
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in carbohydrate-deprived animals there was a much greater rise 
in 
glucose concentrations, and it was only at levels of 150-200 mg1jOO ml 
that hepatic glucose uptake was observed. 
iii) Glucokinase is not present in the young rat bef ore weaning, 
Thus while fed by the mother hepatic uptake is controlled; post- 
weaning when the dietary intake of carbohydrate will vary glucokinase 
becomes necessary for control of hepatic uptakeo 
There is an alternative glucose phosphorylating system present in 
liver tissue, caktalysed by glucose phosphotransferase (EC number not givan) 
but this enzyme is only effective at very high glucose concentrations, 
30mmol/1 and upwards (McCraw 1968). 
Regulation of glucose uptake and release by the liver 
The properties of glucokinase described above can explain the 
mechanisms for glucose uptake by the liver but there is a problem when 
release of glucose is considered. Liver releases glucose when the 
concentration of glucose in the portal vein falls below an optimal 
concentration of about 4-5mmolA- Yet, at this blood glucose 
concentration the activity of glucokinase in vitro is relatively high 
(about 25% of maximal activity). There are no known properties of the 
enzyme suggesting inhibition when the portal blood glucose concentration 
falls below normal* Even the isolated perfused rat liver is able to 
respond to changes in glucose concentration (Williamson et al. 1965) and 
in these circumstances it is only the perfusate glucose concentration 
that is the controlling factor for uptake or release of glucose* 
x4, 
A regulation mechanism must therefore be postulated that involves 
glucokinase and glucose-6-phosphatase and their ability to respond to 
changes in glucose concentration. A small fall in glucose concentration 
can produce a complete change in the rate and direction of glucose flux 
and metabolism by the liver, so it is improbable that glucose alone can 
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S 
act as controller by regulating the enzymes. 
A metabolic intermediate could act in this w* but to provide 
adequate activation or inhibition an amplification system would be 
necessary. There is no evidence for such a regulator or amplification 
system. In the absence of direct corroborative evidence two hypotheses 
have been postulated to account for regulation of glucose uptake and 
release by the liver, namely substrate cycling and compartment atione 
Substrate cycling 
Simultaneous activity of glucokinase and glucose-6-phosphatase will 
result in glucose conversion to glucosa-6-phosphate (with ATP hydrolysis) 
and glucose-6-phosphate hydrolysis back to glucose (Figure 5)- It is 
possible f or such a substrate cycle to be vexy sensitive to changes in 
concentration of a regulator molecule, and could explain the 
physiological role of the liver in releasing and taking up glucose* It 
is necessary for efficient working that glucokinase activity in vivo 
would exceed that of glucose-6-phosphatase and that the level of 
hepaticellular glucose-6-phosphate be relatively constant. Such a 
theory proposing that glucokinase activity varies according to the 
glucose concentration and thus regulates direction and flux of glucose 
metabolism was put forward by Newsholme and Govers (1967)- They 
suggested that as the glucose concentration approached that for saturation 
of glucokinase (about 50mmol) the net hepatic uptake of glucose is given 
by V 
max 
for glucokinase minus a constant rate which represents the 
activitY of glucose-6-phosphatase. As glucose concentration falls and 
approaches normal, the activity of glucokinase with fall concommitantly 
until it approaches that of glucose-6-phosphatass. Around 4-5mmol 
glucose the activities of both enzymes are equal and there is no net 
release or uptake of glucose by the liver. As the concentration of 
glucose falls below this level the activity of glucokinase falls below 
that of glucose-6-phosphatase and hydrolysis of glucose-6-phosphate will 
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occur, with release of glucose into the extracellular space* 
Thus, changes in glucose concentration will control the direction 
of glucose flux and hence metabolism. This hypothesis provides a 
biochemical explanation for the observations that the rate of uptake or 
release of glucose is proportional to the degree of hyper - or hypo- 
glycaemia, (see Figure 6). Such a mechanism is simple, requires no 
specific regulator molecules and relies on glucose concentration onlyg 
but there is no concrete evidence to support or refute ih9 existanceo 
It do es depend on a near constant glucose-6-phosphatase activity and 
hence constant glucose-6-phosphate concentration* Thus the flux into 
the hexose monophosphate pool must be increased when the glucose release 
rate of the liver increases in order to maintain a constant level of 
glucose-6-phosphate. Such a situation could be achieved by increased 
formation of 8lucose-6-phosphate by gluconeogenesis, or alternatively 
by control of glycogenolysis in parallel with glucose-6-phosphate 
hydrolysis (a sort of 'control in series')o Either of these mechanisms 
would implicate modulation of these processes by further hormonal control* 
Many studies have been directed towards determining whether there is 
hormonal control of hepatic gluconeogenesis and much argument devoted, 
especially to the protective role of insulin and if so by what mechanisms 
and at what steps. The many volumes of Advances in Enzyme Regulation 
(ed. G-Weber; 1963 to date) bear witness to this. Numerous enzyme 
reactions have been implicated as it has been demonstratedv principally 
in vitro, that they may be altered in activity as a result of hormonal 
administration or deficiencies. The technical expertise involved in such 
wo* cannot be denied, but the relevancy of the observations to physiology 
must often be doubted. 
However, there is evidence, that the control of hepatic gluconeogenesia 
can be accomplished by varying the rate at which substrate is presented to 
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the liver (Exton and Park 1967; Herrera et al. 1966); that is the rate of 
gluooneogenesis is proportional to the concentration of gluconeogenio 
precursors, and furthermore can be altered very rapidly, within seconds of 
change of substrate concentration. There is overwhelming evidence that 
the provision of gluconeogenic substrate from peripheral tissues is a 
function of hormonal activity within those tissues. 
Thus, enzyme activity may be changed by hormonal alterations which in 
turn will alter the gross limits of maximum and minimum rates for saturating 
concentrations of substrate. Evidence for this view is that normally 
induced alterations invariably occur over a time-scale of hours; whereas the 
alterations in rates of gluconeogenesis occurs within seconds of change of 
substrate c oncentration. 
An interesting further confirmatory phenomenon is that free fatty 
acids by providing for the liver's energy requirements (Herrera'et al- 1966; 
Williamson et al. 1966) spare the gluconeogenic precursors from oxidative 
processes and make them available for glucose formation. Thus at any 
given glucose precursor concentration an increase in the free fatty acid 
concentration will increase the rate of gluconeogenesis. These 
observations suggest that whilst the minute-to-minute regulation of the 
glucose steady-state is a function of the liver, the liver in its turn is 
particularly deperdent on hormones, especially insulin, working on 
peripheral tissues and thereby regulating the rates of precursor release, 
and availability of oxidative substrates The control in series, that is 
activation of the glycogen phosphorylase mechanism in parallel with 
glucose-6-phosphettase, may be a very important mode of provision of 
glucose-6-phosphate. 
Compartmentation theoM 
This theory proposes that glucokinase and glucose-6-phosphatase are 
not simultaneously active because they are compartmented and the products 
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and substrates for the two enzymes are not able to mix 
(Figure 7). That 
is glucoso-6-phosphate may function as a precursor for glycogen synthesis 
or for glycolysis, but not as a substrate for glucose-6-phosphatase. 
The substrate for the latter enzyme is produced by glycogenolysis or 
gluconeogenesia, and its hydrolysis yields glucose that is released into 
the blood and does not have contact with glucokinase. 
This theory is not supported by direct evidence though indirect 
evidence for it is provided by London (1966), Heath and Threlfall (1968) 
and Gumaa, McLean and Greenbaum (1971). The real problem associated with 
this theory is to identify the intracellular location of enzymes. 
Glucokinase is cytoplasmic whereas glucose-6-phosphatase is found on the 
endoplasmic reticulum, but this is not evidence necessarily of a functional 
separation. To be satisfactory as a theory complete physical separation 
of the-glycolytic and gluconeogenic pathways must be postulated, otherwise 
the problems of substrate recognition become insuperable. All in all the 
substrate cycling appears to be the most attractive theory. It is 
anticipated that this mode of control will be one of those factors that 
modelling will highlight. 
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CHAPTER 4 
A CRITICAL REVIEW OF SOME MODELS OF BLOOD 
GLUCOSE REGULATION 
Numerous authors have attempted to explain the relationships between 
the concentration of glucose and insulin in plasma, both of animals and 
man, especially after the steady-state had been disturbed by oral or 
intravenous glucose. However, as has been pointed out by Atkins (1971) 
nearly all these models were inadequate. They could be faulted for one 
or more of the following reasons$ 
i) the proposed model was too complex to be fitted to the amount of 
data available; 
ii) the results available were.. for plasma glucose only; 
iii) the time-scale of the experiments providing datawas too short; 
iv) the models werenot consistent with known physiological and 
biochemical data. 
Atkins (1971) in the light of thdoe criticisms went on to compare 24 
possible theoretical models, all relatively simple. He found 6 
different models conformed fairly well to three sets of data obtained 
from the literature. In other words none was unique. 
It is simplification of a very complex process (Figure 8) that 
yields the problem of non-uniqueness. Simplification requires the 
lumping of several distinct organ level processes as a single quasi- 
linear process and this makes physiological interpretation of simulation 
results very difficult. The introduction of versatile digital computing 
methods has, however, made possible modelling that is increasingly 
isomorphic with. in vivo, systems, and which therefore include the non- 
linearities which normally control the dynamics of the glucose regulatory 
system. The conceptual development of this approach is discussed in this 
chapter. 
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Probably the first attempt to illustrate how the concepts of control 
systems engineering may be applied to the study of glucose homeostasis 
was that of Goldman (1960). In a qualitative fashion he sirm rised the 
major metabolic sub-systems and controlling hormones relevant to glucose 
regulation and represented their inter-connection in a block diagram 
suggestive of a multi-loop feedback control system (see Figure 9). 
Goldman did not attempt to develop his model in any more detail, but 
discussed the eventual application of modelling efforts in characterizing 
clinical abnormalities and in endocrine system research. Assuming that 
glucose regulation can be viewed as a classical regulating system; 
Goldman emphasised the need for now experiments to understand the 
physiological mechanism of set-point establishment and to identify which 
possible modes of control exist in this pbysiological system. Although 
Goldman's work does not enhance our physiological knowledge of glucose 
metabolism per se, it was the first detailed mathematical modelling of 
the system by identifying the major sub-systems involved and their logical 
interconnection in a systematic manner consistent with standard control 
system terminology. 
The next published work is that of Bolie (1961) illustrating the use 
of analog computers in simulation of mathematical representations of 
glucose regulation. The first model treats the interaction of liver, 
kidney, pancreas, insulin and glucose in two compartments, the vascular 
and the extravascular. 
The model is a gross simplification of the glucose regulating 
Watem, treating only one controlling hormone and being strictly linear 
except for a renal threshold. It qualitatively reproduces insulin and 
glucose behaviour after simulated 6-minute infusions of glucose and 
insulin of 50g and 2 units respectively. The model is represented by 
equations (4-1) to (4-4) s 
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vBfv-Ii+ (I 
er 
Iv)P, +X1Gv-K2, v 
i. e. the rate of accumulation of insulin in the blood stream equals 
the rate of injection plus the rate of transfer from the extravascular 
compartment plus the rate at which it is released from the pancreas 
minus the rate at which it is degraded in the vascular compartment. 
vIie. (I 
V7-I e)P, -K 3Ie 
i. e. the rate of accumulation of insulin in the extravascular insulin 
space equals the rate of transfer from the vascular space minus the 
rate at which it is degraded in the extravasoular space. 
(1) 
(2) 
0 V Gj. =G+ 
(G6-G -KG Bi v3 
PG -f (Cý) - Yv 5v 
ioeo the rate of accumulation of blood. glucose equals the rate of 
injection plus the rate of transfer from the extravascular compartment 
minus renal excretion and storage in liver. 
VG 6e w (GV-Ge3 PG7 K Je - K7 Ge 
i. e. the rate of 'accumulation of extravascular glucose equals the rate 
of transfer from the vascular space minus tissue utilisation. 
(4) 
Known non-linear effects have been linearised and represented by 
the constants KI to YI * The, -, -renal nonlinearity f(G V) consists of a 
threshold and constant gain. Although the model does not yield any new 
information about glucose regulation, it does illustrate on a limited 
scale the use of simulation in verifying the consistency of a proposed 
model. 
Bolie's second paper (1961) neglects renal excretion and lumps the 
vascular system and extravascular system into one compartment. The model `V., v 
then reduces to two first-order linear differential equations: 
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j. Ii-I+ 
v (5) 
(6) 
where a represents the sensitivity of insulinase (EC 3.4-99-10) activity 
to insulin concentration, P represents the sensitivity of pancreatic insulin 
output to glucose concentration, represents the combined sensitivity of 
liver glycogen storage and tissue glucose utilisation to elevated insulin 
concentration, and 6* represents the cotbined sensitivity of liver glycogen 
storage and tissue glucose- utilioation to elevated glucose concentration. 
The parameters of this model were derived from data obtained from 
various sources, in some cases values were "averaged" across species % 
No attempt was made to verify the behaviour of the model by predictability 
of experiments. It is evident that at beat the model parameters are chosen 
optimally with respect to one experimont. 
The next published model of glucose regulation was that of Seed, Acton 
and Stunkard (1962). The model related liver, kidney, brain, pancreasq 
vascular and extravascular compartments, ancl a substance Z, presumably 
related to insulin, in terms of three dependent variables connected by 
piecewise linear ordinary differential equations. The equations represent 
respectively, the rate of change of glucose in a "fast" -compartment (minly 
plasma), the rate of change of glucose in a "slow" compartment (intracellular)g 
and the rate of change of substance Z in the liver. The expressions in 
square brackets are zero unless the condition note below each bracket is 
satisfied. 
Gf. -DfGf +Da Go -Lz Gf - 11 a 
Gf -B- (MfGf-mf) - (RGf-r) + (gp7PýZ) + 
(I) 
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(G 
f 
', 7 L: C) 
(Gf>Lv) (Z4Ln) ('4IT) 
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(MSG i-Is) 
(G 
s>L 3) 
i. 
-oz -CzZ+FzG 
(8) 
(9) 
These equations were simulated by trial and error parameter adjustment 
showed qualitative agreement over a limited interval with some kind of an 
"average" of plasma glucose after a 259 infusion taken over 70 normal 
subjects (see Figure 10). These data were obtained by Amatuzio et al. 
(1953)- However, this method of model verification was found to yield 
physiologically unrealistic parameters. 
These investigators then expanded the model to include two new 
compartmente, red blood cells and plasma. The equations representv 
respectively, the rate of change of plasma glucose, fast compartment 
glucose, slow compartment glucose, red blood cell glucose, and substance 
Z in liver. 
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Figure 10 An intravenous glucose tolerance test curve of Amatuzio 
et al. (1953) compared with the predicted values from the model 
of Seedl Acton and Stunkard (1962). 
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(13) 
The authors attempted to substantiate all parameter values from 
published experimental results before computer simulations were 
undertaken. Again, roughly qualitative reproduction of experimental 
results was obtained, and it was concluded that more knowledge of 
glucose metabolism was required before a more refined model could be 
postulated. As hormone effects are not included in this work, the 
deficiencies of the model are substantial. As in the previous two 
efforts, the model is really a sophisticated attempt at curve-fitting* 
In 1964 McLean published a brief st, ry of glucose homeostasis 
focussing primarily on Goldman's (1960) work* He attempted to 
incorporate nervous system effects explicitly in a modified system 
block diagram. However, owing to our very rudimentary understanding 
of mathematical representations of neutil. 1- processes, successful 
modelling of such processes await the results of more basic research. 
Bearing in mind the complexity of the glucose metabolic control 
system I have devised and shown in Figure 11 it can be seen that the 
above mentioned models can only be regarded as tentative attempts at 
achieving some kind of a mathematical representation for certain 
portions of the complete system. Common to all these efforts is a 
restricted emphasis on glucose metabolism, lipid and protein metabolism 
being neglected. 
Although not representative of metabolic system modelling, some 
related work has been done on glucose tolerance test analysis by 
Ackerman and co-workers (see Ackerman et al. 1969 f or a review of this 
approach)* These workers s6ught to characterise a subject's response 
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to a glucose input by one parameter in an attempt to identify normal 
or abnormal system behaviour on the basis of the parameter value. 
Basically, their approach uses a linear second order model and the 
natural frequency of oscillation of the model is the parameter under 
study. The system variables are glucose and insulin concentration 
in blood. For the categorisation of a specific subject, an oral 
glucose tolerance test is performed, the blood glucose concentration 
being determined at timed intervals over a period of 180 min. The 
parameters of the model are fitted to this data in a least-equares 
senseo The resultant parameters then dictate a value for (, ), o ? 
the 
natural frequency of the glucose regulation model (presumably also 
that of the subject). On the basis of experiments on many subjects 
they concluded that classification of normalsveo diabetics in terms of 
9) 
0 was comparable 
in reliability to previously used techniques, though 
they also recognise that borderline cases are difficult to classify-4 
Considering the complexity of the system however, it would be 
rather surprising if a useful tool could result from the least-equares 
fit of a second order equation to the coarsely sampled response of the 
metabolic system to an oral glucose load. 
Early in 1967 Cerasi published the results of some work done in 
Sweden on analogue simulation of glucose regulation. The model 
represents insulin and glucose in one comparb=t and includes renal 
excretion, peripheral glucose uptake, and insulin secretion. The 
release of insulin in response to glucose concentration is represented 
in two phases, the release of stored insulin ard the release of newly 
formed insulin, The model is not strictly linear, since the uptake 
rate of glucose by peripheral tissue, for example, is represented as 
proportional to the product of insulin and glucose concentrationsq and 
a renal excretion threshold is included. 
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The author claims successful simulation of many oral glucose 
tolerance tests performed on humans in their laboratories. The 
intention of the author was to represent in a mathematical fashion the 
alterations in glucose and insulin concentration after a glucose load 
by means of a lumped model. However, it is apparent that the model is an 
insufficient representation of the glucose regulatory system, considering 
what is known today about the metabolic processes involved and their 
humoral controls. 
A somewhat different approach has been taken by Kadish and his 
group. Owing to the complexity of the system depicted in Figure 11 and 
the paucity of experimental data that can suggest reasonably valid 
analytical models for the relevant sub-systems, these workers tried to 
construct models using as small a set of basic analytical blocks as 
possible with parameter values chosen for ary specific process within 
a given class to accommodate the behaviour of that process. The real 
objective of this work is to demonstrate by means of examples what 
control systems techniques can contribute to our understanding of these 
biological regulation systemse Although a great amount of physiology 
has yet to be learned about the relevant sub-systems involved before a 
definitive model can be established, it is the belief of Kaaish and his 
group that the systems analyst can contribute to this effort by 
systematizing knowledge about the metabolic system in a consistent 
mathematical framework; and providing ideas tovthe physiologist about 
specific experiments suggested by model building, simulation, and 
analysis, and by determining analytically the consequences of conflicting 
theories concerning the operational dynamics of specific portions of the 
system. 
Recognising that the system contains inherent nonlinearities such 
as saturation effects and threshold phenomena, the models were constructed 
from first order nonlinear differentik equations. All the models are 
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simulated by digital computer and compared to actual data from controlled 
experiments in humans. Charette, Kadish and Srinavasan 
(1967) presented 
a report on some preliminary results in modelling of hormonal control of 
glucose metabolism. This work treated the glucose loop with two 
controlling hormones , insulin and glucagon 
(see Figure 12). The system 
is considered to be representative of a normal, 70 kg unstressed adult 
subject; sex hormones are neglected. Initial conditions are intended to 
depict a normal human plasma glucose regulator in a steady-state, iOe in 
metabolic and endocrine equilibrium, hence parameter dependencies are 
represented in terms of deviations from the nominal. 
Hormone generation is modelled on the basis of the sequence, 
secretion, accumulation, and depletion. Physiologically, hormone 
secretion rates monotonically increase from nominal until saturation 
occurs. This action is modelled by the smooth and symmetric nonlinearitY: 
1' r0+a tanh (p (e-eo)) (14) 
where r is the hormone secretion rate in (mass/unit time) and e is the 
stimulus. This particular analytic form was chosen with a view to 
simplifying the inverse or identification problem, which amounts to 
either a parameter optimization or two-point boundary value problem if 
and are assumed constant* The function 14 reproduces thO so-called 
"hyperbolic" behaviour of first-order Michaelis-Menten rate kinetics and a 
the so-called "sigmoid" behaviour of a series of such reactions with 
sufficient accuracy until more precise analytic forms are justified by 
PbYsiological data. Such functions are used to model glycogenolysis, 
glycogenesis, insulin secretion and glucagon secretion. Following 
several investigaýors, the effect of hormones on the function (14) is 
modelled as a linear change to the saturation value of the non-linearity. 
For example: 
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Figure--12 
The early glucose model of Charette et al. (1967) involving two 
hormones, insulin arxI glucagon. 
Image removed due to third party copyright
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I. - 
a 0 
ro +a tanh (P (e-eo)) 
(r 
h+ rl)/2 
(15) 
(r,, - rl)/2 
rh - ýh + rho (ii) 
where h is the pertinent hormone concentration affecting the lumped rate 
kinetics (see equation 14), andlis a constant. Accumulation and 
depletion are modelled by first-order kinetics,: -in which it is assumed 
that the degradation rate is proportional to the concentration, ie. 
fi - -k2h + k, r 
where k2 has a value (f) and kI has a value (f 
1) The 
(18) 
parameters kI and k2 have been measured by various techniques, eg, 
radioactive tracers, for several hormones, kI representing the circulatory 
volume and k2 the degradation factor. 
Consider the problem of establishing parameter values for the 
hormone model based on physiological data. 
k2h+k+f 
e) 
rý Mr0+a tanh (P (e-eO)) 
where f. represents an exogenous input of the hormone h. Suppose the 
hormone under consideration is insulin, vhere (14) represents the 
generation and release of insulin from the pancreas into the plasma. 
Then we must identify k,, k 29 rop aq P, and eo Theoretically the 
identification can be carried out in two steps. We will assume perfect 
observations to simplify the illustration. 
If we administer fe (t), a Imown quantity of insulin intravenounlyg 
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the resulting : bypoglycaemic state implies that r-0 in (19) ie, the 
endogenous production of insulin is at or below its nominal value. 
Adjoining the parameters kI and k2 to the differential equation (19) 
we obtain 
0 h k2h +k1f 
fc 0 
0 k2 
(20) 
Given the input f (t)9 0tj arxl three measurements of fi(t), h(t 0 
i=1.2,3, these data and (20) constitute a multipoint boundaxy value 
problem which can be solved for k1 and k2 by the technique of quasi- 
linearisation. After each iteration the specific kI and k2 obtained 
are substituted into (19) and the equation integrated to yield 
r2(t) 
,0 -4 t4T* Given some 09 the process is repeated until 
some criterion such as, 
32 
Lh(t Rt i) 1 . 9:::. 
is satisfied# 
(21) 
Now assuming kI and k2 fixed, and f O(t)19 
0, a glucose input can 
i 
be administered dictating e(t), 0)tIT Identifying rig e of 
a9 
and p can now theoretically be done in a similar manner with a minimum 
of six measurements on h(t) by solvingý 
0 h- -k 2h +kI 
(ro +a tanh (P (e-oo)) 
ý-aP sechF (p (e-eo)) 9 
a. 
(22) 
ý. 
0 
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and satisfying an expression such as (21). 
Returniz)g to the discussion of the first glucose regulation model 
derived by the authors (Figure 12), it can be more compactly written 
as follows : 
6. k 19 c+K 18[F + tLO(cl x 21 - t,, 
(Olx,, 73) - tR(c) -tu (c, x, ) -GU)] 
(23) 
where: 
c 
x 
x2 
73 
F 
GU 
I 
G 
f LO(C IX2) 
fj; j(c, x I" 73) 
fR(c) 
fu(cgxl) 
19 
il , K8xl + Yl (I +f1 (0)) 
(24) 
i2mK 
11 x2+K, O(G +f 2(C» 
w 
m 
in 
(25) 
plasma glucose concentration 
plasma insulin concentration 
plasma glucagon concentration 
liver glycogen content 
intravenous glucose input rate 
central nervous system mean glucose 
utilisation rate 
intravenous insulin input rate 
intravenous glucagon input rate 
= liver glucose output rate 
w 
liver glucose uptake rate 
renal excretion rate 
peripheral tissue glucose utilisation rate 
dependent on ibdulin 
hormone independent, tissue utilisation rate 
coefficient* 
Numerical values for the model parameters were obtained from 
results in the literature. Refinements were made by simulating 
experiments in which glucose or insulin were administered under 
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controlled conditions. All intravenous injection of glucose or insulin 
appears to the system as an impulse function. It was found that a 
finite duration stop function was an adequate representation of such a 
test input. Simulations which correspond to tests ranging in duration 
from one to six hours in real time were performed. 
The model more recently under consideration still focuses on glucose 
metabolism, but with four controlling hormones, insulin, Slucagon, 
epinephrine, and growth hormone. The model for the metabolic system is 
shown in Figure 13, depicting the control of liver function, renal 
function, muscle and adipose tissue utilisation of glucoseq by four 
controlling hormones through parametric feedbackq in a one-compartment 
configuration. The model being used for the four-component hormonal 
controller is shown in Figure 14 and includes both proportional and rate 
sensitive control modes. 
The signals for hormone action are taken to be glucose error and 
error rate. The model can also be rePresented as follows: 
%^ 0 
C 1801 + a, ,G 18 
(F(t-Tl) + fjo(cl th 2 gh 3) - fLV(cl9x49 hIfr 
(c 
1) - 
0 901 - fM(lll) - fL(XII; h 4» (26) 
K6h +K5fKI (h 3) [f, (c, ) + f2(61)3 +I (t-rt'2')ý (27) 
h+ Klo [f (c1) +G (t-rt')] 11 2 
(28) 
fi - -K2, h +K (c )+f (c) + E(t-T, )] (29) 33 2P4 154 
A -- -X h 31 4+ 'C3if6(cl) + s(t 
C5)3 (30) 
wheret 
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Figure 13- The glucose metabolic system incorporated in the 
model of Charette, Kadish and Sridhar (1969). 
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Figure 14- The hormone controllers incorporated in the model of 
Charette, Kadish and Sridhar (1969). 
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(31) 
The parameters of this model were adjusted to simulate the results 
of experiments. 
This group claims (Charette, Kadish & Sridhar 1969) that their model 
was successfully used to simulate the results from two experiments, one 
involving a short intravenous infusion of glucose over three minutesq and 
the second, in which five units of insulin were injected intravenously 
followed 'ýy I mg of glucagon 60 minutes later. However, no confirmatory 
evidence of these simulations was presented in the review. 
Howeverg Srinivasang Kadish and Sridhar (1970) presented another model 
based upon the earlier model of Charette, Kadish and Sridhar (1969) which 
probably represents the most sophisticated attempt to date, though its 
complexity is in no way a guarantee as to the correctness of the model. 
Non-linearities such as thresholds andzaturation effects were generated 
with a hyperbolic tangent function with the following ohararterictics: 
its-lower and upper saturation values and the steepness of the rise from 
one to the other were adjustable using three parameters. The upper 
saturation value, when postulated to be parameter dependent, was linearly 
dependent. The model included the substrates, glucose and free-fatty 
acids, and the hormones insulin, glucacon, adrenaline and growth hormone. 
The ýlucose distribution space included the plasma and 'interstitial 
compartments. Gluconeogenesis was assumed to be brought about by raised 
free-fatty acid concentration, and its saturation level was regulated by 
the plasma glucagon and adrenaline concentrations. Hepatic glycogenolysis 
was assumed to be stimulated by a faW of theglucose concentration below 
the resting plasma glucose concentration. The'saturation-value'of-this 
Process was also regulated by the samet'wo hormones. Glycogen synthesis 
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in the liver was set to respond to the deviation of the plasma glucose 
concentration above the fasting level. The saturation of this process was 
regulated by the plasma insulin concentration. 
Insulin secretion was responsive to both the change in plasma glucose 
concentration and in the rate of change; adrenaline at raised concentrations 
inhibits this secretion. Insulin distribution included plasma and 
interstitial fluid compartments. Glucagon secretion was inversely related 
to the plasma glucose level. Adrenaline secretion was assumed to be 
responsive to the plasma glucose concentration and its rate of change* A 
single distribution volume was assigned to adrenaline. Growth hormone 
secretion was assumed to respond to the plasma glucose concentration. 
The incorporation of all these variables made this a very complex model, 
with the glucose portion containing forty parameters alone., The model was 
validated with data obtained from intravenous glucose and insulin injections 
in two subjects. The plasma glucose, insulin and free-fatty acid responses 
were fitted to the model. These results are apparently the same as those 
mentioned in the earlier paper. However, a n=ber of additional tests were 
performed with the model without using experimental dataq to show that 
expected conformations or trends in the responses could be produced. These 
tests were intravenous boli of glucagon, adrenaline and growth hormone. 
Although the model does not reproduce adequately the finer details of 
the actual responses, as represented by the laboratory data, the authors 
feel that their limited success was vindication of their approach. Yet a 
further description of the use of this model was given by Campfield (1973), 
who emphasioed the correspondence of the model with the real physiological 
system. He also considered the principal deficiencies of the model were 
the omission of the corticosteroids, catecholamines and the autonomic nervous 
system. The model was claimed to simulate various forms of hypoglycaemiap 
but no confirmatory evidence is presented. 
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Recently Foster et al. (1973) have described a model incorporating two 
substrates, glucose and free-fatty acids, and two hormones, insulin and 
glucagon. The non-linearitiee of the model are generated by table 
functions (function generators) which produce piece-wise linear curves. 
The glucose pool includes a mixing compartment, muscle and the liver. 
The rate of change of glucose concentration is assumed to be governed by 
both insulin and glucagon acting in an antagonistic mannerg whereas that of 
free-fatty acids is affected by insulin only. Nervous system and red blood 
cell glucose consumptions and the kidney threshold for glucose were included. 
The secretion of insulin was related to the glucose level in the glucose 
space, to its rate of change, and to the FFA level. The secretion of 
glucagon was related to the glucose level. Effects on adrenaline were 
incorporated as enhanced glucose output by liver, increased FFA release and 
depressed insulin secretion, all following hypoglycaemia as a stimulus to 
epinephrine secretion. 
The model was validated with oral and IV glucose tolerance testsq and 
studies were performed to characterise thd diabetic state'that the normal 
glucose tolerance test was dominated by changes in insulin secretion 
dependent on changes in the level of glucose. The model was vexy insensitive 
to changes in the size of the glucose space (50% increase and 2Y, 4 decrease 
had almost no effect). 
This paper by Foster and his co-workers presents a non-linear complex 
model of glucose regulation in man that can apparently successfully simulate 
experimental results even when certain of the criteria of the model do not 
fit real conditions. On the other hand, it represents a failure of the model 
to offer insight into the physiological processes because the model behaviour 
can be'satisfactory in the absence of reasonable degree of isomorphism to the 
physiology. The model was developed as part of a project to construct an 
"artificial beta cell" for use in the treatment of diabetes. This work 
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presents an interesting and important attempt to reconcile a clinical 
engineering approach and a physiological one. Certain defects of the modelq 
as initially conceived in simulating observed behaviour, led to its 
modification. This awareness of the ability of modelling to suggest new 
experiments, led the author to present a revised theory of the nature of 
control of insulin releasep though the evidence is slight. 
The inherent weakness of the models of Srinivasan et al. (1970) and 
Poster et al. (1973) is that whilst structurally isomorphic they are not so 
functionally. Both groups have suggested that their system performance is 
adequate but as with so many other modelling attempts they are conformational 
in nature. For instance neither is able to reproduce the oscillatory 
behaviour of the plasma glucose metabolic system which has been demonstrated 
in vivo (Iberall, Ehrenberg & Cardon 1968). A possible reason for this is 
that the representations chosen for the most significant parts of the system 
do not reflect the most important non-linearities of the sub-systems. it 
is therefore obviously necessary to identify and define the dynamic 
characteristics of the most relevant unit processes of the systemg namely 
the enzymes involved. 
Several factors are involved in the regulation of enzyme activity. 
In the work described below only the direct modulation of enzyme activity 
is considered; the entire area of genetic control, where the amount of 
enzyme directly synthesised can be regulated by induction, repression and 
deiepression is excluded. Direct control can occur in one of two ways: 
either through the catalytic mechanism or by coupling the catalytic 
mechanism with other processes. 
The simplest form of control, and probably the most primitive, of the 
catalytic mechanism is the saturation type of kinetics normally governing 
enzyme reactions. As substrate concentrations increase, the rate of 
reaction increases until a limiting value is attained; as product accumulatOs 
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the reaction rate is decreased by product inhibition. In this process the 
substrate and products act as "on" and "off" switches' and the concentration 
of metabolites can regulate the catalytic rate# A similar control occurs 
with coenzymes, though the concentrations of coenzymes are normally not 
sufficient to saturate all coenzyme requiring enzymes, so that in turn the 
relative coenzyme affinity and enzyme concentrations provide some regulation. 
azymes with a single ligand binding site give binding isotherms that 
are always hyperbolic. However, with enzymes that possess multiple binding 
sites, usually implying multiple subunits, nonhyperbolic binding isotherms 
are possible. In cases where binding is enhanced as successive ligands 
bind, sigmoidal isotherms are obtained, and this found even where multiple 
subunits are formed from cheemially identical subunits. A sigmoidal 
binding curve has a region where the degree of saturation is more sensitive 
to the substrate concentration than the hyperbolic isotherm; therefore the 
enzymatic reaction rate can be closely regulated by the substrate concentra- 
tion. Contrariwise the binding may be depressed as successive ligands bind, 
providing an alternative control process. 
Enzyme activity may also be controlled by coupling the catalytic 
reaction to other processes which usually involve regulation by ligands not 
participating directly in the reaction and often structurally unrelated to 
the substrates. Typical examples are feedback inhibition, vhere the 
metabolic end product of a pathwV controls its own production by inhibiting 
the activity of an early enzyme in the pathway (Umbarger 1961); precursor 
activation, where an early metabolite activates a later enzyme in a 
metabolic sequence (Ijdloir and Goldenberg 1960); polymerisation - 
depolymerisation triggered by protein concentration changes or ligand 
binding (Prieden 1968): energy link control by adenylates (Atkinson 1969) 
and hormone control, where the dAails of regulation are as yet not well 
understood, although cYdlic -3', 51- AMP is thought to have an important role 
(Robison, Butcher and Sutherland 1971). 
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Multienzyme complexes provide a further type of enzyme regulation. 
By combining two or more enzymes into a single molecular aggregate the 
activity of the individual enzymes can be modulated through protein - 
protein interaction. Also catalytic features can arise, such as processing 
a substrate through several enzymes without dissociation. 
The membrane also provides a potential basis for modulating enzyme 
activity, not only by localisation, but by altering the enzymatic reaction 
through protein-lipid interaction. However, such systems are difficult to 
study as isolation of the membrane invariably disrupts the homogeneity of 
the system. 
Thus, any approach to understanding regulatory mechanisms must involve 
structural, thermodynamic and dynamic considerations. In this work the 
emphasis is upon the dynamics of control together with: an attempt to make 
use of structural data. In the next chapter details of the mathematical 
model based upon these concepts is described. 
I 
I- 
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CHAPTER 
DESCRIPTION OF THE NM, MODEL 
The development of the model to describe glucose dynamics in the mode 
detailed here, that is in terms of enzyme kinetics. requires knowledge of: 
i) the rate determining steps in the reactions; 
ii) the kinetics of each reaction; 
iii) the factors regulating the enzyme involved; 
iv) and the kinetics of flux (rates). 
The reactions considered in the model are depicted in Figure 17 and 
these biochemical features and certain physiological assumptions were 
incorporated into the model. I 
1. Biochemical Features of the Model 
In the liver there is no permeability barrier to glucose - the hepatocyte 
membrane being freely permeable. Thus the membrane is neglected in the 
model and the glucose concentration assumed to be equal in plasma and liver 
water (Cahill et al. 1958; Gey 1956)o This assumption would appear to be 
valid, for [14C]glucose rapidly equilibrates with the intracellular pool 
and the rate of equilibration is independent of the direction of glucose 
flux. Thus the rate-limiting step in glucose utilization by hepatic 
tissue is determined by the glucose phosphorylation rate, rather than the 
rate of entry into the cell (Cahill et al. 1959)- 
The rate of glucose-6-phosphate production by glucogenesis, is fixed 
at Ix 1074 M per minute, which is near the rate obtained for incorporation 
of labelled pyruvate into glucose and glycogen in experiments performed 
by Ashmore et al. (1956) using liver slices. It is further assumed that 
in the steady-state this constant rate is the resultant for the pathways 
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glycogen 
phosphorylase 
UDP-glucose pyrophosphorylase 
glucose -1- phosphate 
phosphoglucomatase 
glycolysis glucose -6- phosphate - gluconeogenesis 
hexokinase 
(glucokinase) glucose -6 phosphatase 
liver glucose 
it- 
plasma glucose 
Figure 15 The enzymatic reactions involved in the mathemntical 
model. 
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that yield glucose-6-phosphate and those that utilize this compound. 
It is also assumed that the reactions involved in the branching and 
debranching of glycogen, can be ignored as their processes occur Only 
at the periphery of the molecule of the glycogen polymer (Stetten and 
Stetten 1960). 
The reactions involving conversion of UDP-glucose to UDP-galactose 
and UDP-glueuronic acid, are also ignored, as they are minor and are 
not directly concerned with the storage or dissimilation of glycogen. 
Rnzyme mechanisms 
Enzyme reaction rates have been specified in terms of data obtained 
from in vitro experiments described in the literature. The data has 
been interpreted in terms of individual reaction mechanisms, using 
Briggs-Haldane kinetic theory (Briggs and Haldane 1925); that is, 
assuming the practical and approximate steady-state. This steady-state 
is assumed to be of such a relative and temporary nature (Chance 1943)9 
that it can be directly applied to trafisient states (see Appendix I). 
Thus, enzymatic rate equationsv ox more correctly enzyme kinetic 
equations, were derived directly from the reaction mechanisms for the 
enzyme substrate (Cleland 1963)- 
The enzymatic mechanisms and the appropriate rate equations appear 
in Table II. 
Glucokinase (E. C. 2.7.1-12) and Hexokinase (E. C. 2.7o'l. 1) 
The rate equation for glucokinase is a modified Briggs-Haldane 
equation where V is the maximum velocity, and the kinetic constant of 1 
the substrate was determined in the presence of a high concentration of 
the other substrate# The empirical equation is consistent with the data 
of Salas et al. (1965) with inhibition by ADP omitted. This latter - 
inhibition is poorly understood. In the normal subject 
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Glucokinase 
ATP + Glucose + E, Glucose-6-phoophate + ADP +E 
VI 
Phosphoglucomutase 
Glue ose-6-phosphate +E-P+ G19 6 di-P -ý'- Glucose- 1-phosphate 33 Itz- 
vIG 
G (KýTp / ATP +I 
2) Glucose-6-phosphatase 
Glucose-6-phosphate +H 20 + E2 Glucose + Inorganic phosphate + E2 
V2G6P 
ý6P 
+ G6P 
3) 
- Pl 
v3- 
(v 3- G6P) (v .3. GIP) 31' KýIP 32K66P 
v3 3 G6P 32 K66P K 
eq - GIP v3 31 YýIP 
4) Glucos&-I-Phosphate uridylytransferase -, 
Uridine triphosphate + Glucose-l-phosphate, + 
v4= 
E4* Uridine disphosphate 
glucose + Ppi +E4 
V41 V42 (UTP. GlP) _- (pp i UDPG/4 q) 
lp -v 42 - UTP) + 
(4DEG *v 41 * pp/4 q) +v42 
(4TP 
UTP). GlP + V41 (K pp + 
PP). UDEG 
2 K4 
K4 PP. UDPG 
V41 
pp 
4DPG 
eq - UTP. GlP - V4-2 44 YýTP YýlP 
Table II Enzyme mechanisms and rate equations 
+ 
[cont'd] 
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Glucogen-synthase 
-. 'j Glucose-6-phosphate E5 
C 51 + Uridine diphoOPhate glucose 
E5+ Uridine diphosphate glucose 
v5'v5 
PhosphoMlase 
1 
, KZ 
2\ 
4 
qcz--- 
Adenosine monophosphate 
Glucose-6-phosphate + E6 
c3 
61 +p C63 
1 
", Z 
2 
4' 
Is' 
51 
C52 -3ý, 
C51 + products 
c 
53 )o 
c 62 
C64 
products 
- qz 
c 61 + GlP 
6M 413 K6. G 
v 
(V61 * 1ýj IP P) - 
(V6 
2P 
.. 
6 
.. 
6 
-- ,6-, 
T-/, 6 
C61 
G6P + (k 5/k). 
"ý51*K523 /K5', ) U')FG 
X52 (06P + K51) + (EY'51 K52/K5'33 + G6P) UDFG 
6-6 K6.6 6 Yýjp- P+Kp. GlP 4. p 
"ýIp (KýM, 3, 
/AtT ([G6P 6P] + 1) + 1) 
v6 
K6 p 
62 Y'i 
eq G-1-P 6 V6 I Ký_ I _p 
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glucokinase accounts for about 80% of the phosphorylating capacity of 
hepatic tissue (Salas et al. 1965; Vinuela, Salas and Sole 1963; Salas, 
Vinuela and Sols 1963; Sharma, Rajani and Weinhouse 1963). The 
contribution of hexokinase accounts for the remaining activity. 
GlucosG-6-phosphatase-(E-C-3-1.3-9) 
The mechanism proposed by Hass and Byrne (1960) for glucose-6- 
phosphatase has been used; the rate equation is a typical Briggs- 
Haldane equation. Any slight inhibition by Glucose and inorganic 
phosphate is neglected (Hass and Byrne 1960a; 1960b). 
Phosphoglucomutase (E. C*2.7*5ol) 
The mechanism for rabbit muscle phosphoglucomutase as suggested 
by Najjar and Pullman (1954) has been incorporated. Kinetic constants 
for the rate equation were calculated using the data from Bodansky (1961) 
with initial conditions for the reaction including the presence of excess 
cofactor. This yielded an equilibrium constant of 12.7. 
Glucose-l-phosDhate uridvlvtran erase (E. C. 2-7.7-9i UDP-glucose 
pyrophosphorylase) 
The mechanism incorporated for UDP glucoseý. pyrophosphorylase was 
that proposed by Munch-Petersen (1955) for yeast, The. equilibrium 
constant of unity as suggested by Kornfeld (1965) is accepted., The 
kinetic constant for one substrate was determined with excess'substrate 
but in the absence Bf products. The dissociation constants for UTP 
and UDP-glucose are assumed to be large and are not incorporated. 
Glycogen synthase (E. C. 2-4-1-111 UDP-glucose-glycogen glucosyl transferase 
The mechanism used asswries that glucose-6-phosphate affects the 
kinetic content for UDP-glucose but not the maximum velocity constant 
(Kornfeld and Brown 1962; Traut and Lipmann 1963; Rosell-Perez and 
Larner 1964) which implies that glucose-6-phosphate combines 'initially 
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with the enzyme. The liver enzyme is strongly dependent on glucose-6- 
phosphate (Loeloir and Goldenberg 1960; Steiner and King 1964)- However, 
the possibility of catalysis without is included to simulate conditions 
for varying concentrations of glucose-6-phosphate. The mechanism assumes 
excess glycogen and no effect of UDP. 
Glycogen Phosphorylase (E. C. 2-4-1-1) 
. 
The properties of hepatic glycogen phosphorylase have not been so 
those of 
closely studied asAhe muscle enzyme, and it is not very clear how the 
inorganic phosphate concentration varies with glucose concentration* 
Therefore, the rate of phosphorylase is maintained near constant as an 
approximation. To account for changing phosphate concentration a 
reaction mechanism based on data for muscle phosphorylase b is used 
(Helmraich and Cori 1964; Morgan and Parmeggiani 1964)- 
This assumes dependence upon 5'-AMP, inhibition by glucose-6- 
phosphate and excess glycogen. The observation of Helmreich and Cori 
(1964) that 51-AMP does not affect the 
V 
max implies that this activator 
combines with enzyme before substrates* 
The suggested mechanism predicts that the. observed kinetic 
constants for Pil glucose-l-phosphateg glucose-6-phosphate and 5-Ak? 
may vary- with changing concentrations of substrate,. activator or 
inhibitor. However, true kinetic constants are obtainable which are 
independent of the concentration of any substance (see Appendix Ififor 
the method of calculating these constants). The equilibrium constant 
calculated from these data is 3-1 at pH 7-5- 
With near constant phosphorylase activity the model is not 
dependent an this mechani= of reaction or rate equation except when 
the inorganic phosphate concentration is varying/changing. Small 
changes that occur in phosphorylase activity are, the result of slight 
glucose-6-phosphate inhibition, for phosphate and 51-AMP concentrations 
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are constant and the low glucose-1-phosphate does not produce a 
significant back reactione Dependence of phosphorylase on-5'-AMP 
and glucose-6-phosphate inhibition are a means to simulate slight 
changes in enzymatic activity. 
The derived input constants used in the preient model are given 
in Tablo III. 
The values were obtained from the literature with the following 
exceptionst 
i) Constant concentrations of UTP and PP i were used to simplify 
calculatione Reported UTP and PP i concentrations together with a 
UDP-glucose concentration of 3x IC4mol (Hornbrook, Burch and Lowry 1965) 
and an approximate physiological glucose-1-phosphate concentration of 
4x 107 
6 
mol predict not UTP production by UDP-gluoose pyrophosphorylase. 
This would suggest that the PP i concentration is too high 
(or UTP 
concentration is too low) as the enzyme catalyses UDP-glucose production 
as part of the glycogen synthesis system. 
ii) In order to have adequate synthase activity, yet assuming a strong 
dependence on low glucose-6-phosphate conceýiratlons (Hornbrook, Burch 
and Lowry 1965) a small dissociation constant for glucose-6-phosphate 
was chosen. However, the precise determination of this constant is 
difficult. 
iii) An alteration in the maximal velocities of phosphorylase is 
necessary to ensure a physiological balance between the phosphorylases 
and glycogen synthase. The 
v 
max of the two enzymes is similar but the 
very low glue ose-6-phosphate concentration limits the glycogen synthase 
activity markedly. This alteration in phosphorylase activities high- 
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Kinetic 
data Value Source of value 
v1 2-5 x C3 Salas et al. 1965; vinuela, Salas and Sols 1963- 
4 2.27 x 10 -2 
1 
KjTp 3.00 x 10-4 
V2 1.20 x 16-2 
46P 
31 
v 32 
K3 G6P 
3 "ýIp 
V41 
v 42 
0 
UTP 
41P 
4DPG 
2.00 x C-3 
1-04 xI C72 
3-77 x lc7 
2 
8.65 x 16-5 
2.46 x 10-5 
l. o6 
5 -90 x 107 
2 
3.00 x 107-3 
1.00 x 1073 
9.0 , 1075 
4p 1 . 54 x 10-4 
V5 3.12 x 107-3 
K 51 1-5 x IC74 
K5 2 
IC53 
4-5 1C 
K54(K5/K3) 0 
Walker 1963- 
Walker 1963- 
Weber and Cantero 1955; Dickens, Glook and 
McLean 1959- ý 
Hass and Byrne 1960; Segal and Washko 1959- 
Vollar-Palasi and Larner 1960o 
3 Calculated from K 
eq 
Bodansky 1961. 
Bodansky 1961. 
Calculated fromK4 
eq 
Villar-Paladiand Laxmer 1960. 
Breckenridge et al. 1961. 
Breckenridge et al. 1961. 
Kornfeld 1965- 
Breckenridge et al. 1961. 
Leloir et al. 1959* 
Leloir and Goldemberg 1960s 
Leloir and Goldemberg 1960. 
Table III* Kinetic data and constant concentrations. [cont'd] 
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Kinetic 
data 
V61 
v 62 
4 
41P 
4ý 
46P 
Gluconeo- 
genesis 
Value 
1.25 x 
3-12 x 
1.00 x 
8.00 x 
3.60 x 
2-50 x 
1.00 x 
1073 
107 
1073 
1074 
ci-4 
10-4 
1074 
Constant Concentrations 
ATP 2-45 x lo; -3 
UTP 1.80 x 1073 
ppi 1.60 x 10-5 
p1 3-00 x 1073 
AMP 1-30 x 1074 
Source of value 
VJllar-Pa3. asi and Larner 1960. 
Calculated from K6 
pq 
Heloreich and Cori 1964- 
Helmreich and Cori 1964- 
Helmreich and Cori 1964. 
Morgan and Parneggiani 1964. 
Ashmore et alo 1956 
Heldt 1963. 
Heldt 1963. 
Heldt 1963. 
Heldt 1963- 
Heldt 1963. 
Note The units of the velocity constants and for gluconeogenesis 
are moles litre- 
1 
mirr' those for the kinetic constants and 
concentrations moles litre- 
1# 
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lights the inadequacy of the phosphorylase scheme, but the complexity 
of which could be overwhelming, if for instance the interconversion of 
active and inactive forms was introduced. The activity of the enzyme 
was maintained near constant in the model. 
Alteration of the maximal velocities is the simplest way of 
limiting the activity but alteration of the kinetic constants or 
concentrations of reactants would be as effective. In this study 
variation of the phosphate concentration is thought to be important. 
If changes in K 51 'V 61 and V 62 are not made glycogen 
breakdown 
will exceed its synthesis and the rates would only be equal at 
unrealistic levels. 
II. Further assumptions concerning model function 
i) Plasma glucose concentrations below nominal ie. resting or fasting 
level (negative glucose error) will bring about glycogenolysis while 
concentrations above nominal (positive glucose error) lead to glycogenesis. 
a^OL The former process is facilitated by glucagon and adrenaline 4 the latter 
process by insulin. 
ii) Gluconeogenesis is facilitated by glucagon and adrenaline. 
iii) Glycogen storage in the liver is limited by a saturation concentration 
of approximately 251=01 of glucose as glycogen per gram of liver. That 
is, the glycogen content of the average. 1500 g liver is about 70 9- 
Glycogenesin is cut off when the glycogen stores reach their capacity. 
iv) There is no renal excretion of glucose below an assigned threshold value 
of plasma glucose concentration. 
V) The utilisation of glucose by cerebral tissue and the erythrocytes is tit 
a constant rate independent of the plasma glucose concentrationS 
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vi) The rate of glucose uptake by peripheral tissues is a function of 
insulin concentration, in the interstitial tissues, which facilitates the 
active transport of glucose across the cell membranes. 
vii) The dynamics of glucose distribution are determined by two compartments: 
the extracellular fluid, including plasma, erythrocyte and liver water 
volumes, and. the intracellular fluid volume. This lumping of plasma, 
hepatic and erythrocyte glucose is justified because of the rapid equilibra- 
tion of glucose concentration in liver and erythrocytes with that of the 
plasma. 
viii) The hormones included in the model are insulin, glucagon and 
adrenaline. All are involved in homeostasis. 
ix) Glucose error stimulates the secretion of these hormones- Positive 
glucose error stimulates insulin secretion, negative error glucagon and 
adrenaline secretion. 
X) The insulin and adrenalin secretion rate is stimulated by a high 
glucose error rate. 
xi) Adrenaline inhibits insulin secretion. 
xii) Hormones are distributed and degraded in a linear fashion, 
III. Formulation of the fdathematical Model 
It was realised that it would not be feasible to produce a-realistic 
model of the metabolic system shown in Figure 11 in terms of all the unit 
processes as there are too mary gaps in our knowledgee 
The initial attempt to produce a mathematical model was based on the 
reduced model shown in Figure 16. 
All the systems studied were considered as an assembly of interacting 
compartments and a mass balance equation written for each. The rate of mass 
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v/ I 
hepatic 
glycoge'n 
Sluzogenesis 
----> glycolysis 
Figure 16. The reduced functional model of liver 
glucose metabolism* 
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transfer from compartment to compartment would be dependent upon the 
quantity of substance in the source compartment and a function of the 
kinetics of the enzyme reaction involved. 
The following model notation was adopted: 
Variables 
Xn a concentration of substance in the nth compartment 
Kmn = rate constant associated with transport of material from 
compartment m to compartment n (min-') 
f=(Xm) - non-linear function of Xm, describing rate of change of 
concentration during transport from m. to n 
K= constant rate of change of concentration (mol/min) 
A primed variable indicates a threshold value. 
Subscripts (indicating location of substance) 
I- Plasma glucose 
2- liver glucose -6- phosphate 
3- triose phosphate 
4- glycogen 
5- Pyruvate 
6- insulin 
7- glucagon 
8- adrenaline 
9- liver triglyceride 
0- represents basal. secretion rate 
a- oxidation 
b- brain glucose compartment 
c- lactate 
ie associated with insulin 
is associated with glucagon 
E is associated with adrenalin. 
i 
Using this notation the following mathematical description of the model was 
obtainedt 
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Plasma glucose compartment 
dX 
-w 
dt 
exogenous glucose dose rate +k 21 x2-k Ib - f12 
(X 
1) 
Glucose -6- phosphate compartment 
dX 2 
- IF Ir dt - -32 -3 - -23 -2 
I 
kX+f (x 6 
I 
21 2 12 1) 24 
(X2) f or X6 X6 
1 0f or Xx 61 63 
II 
[f or X7> X7 OIl X8> X83 
ý: ror X7 4' X7 A14D X84 X81 
Trioss phosphate compartment 
dX 2kkxk [for X Tt- k5 3 X5 35 X3 - k32 X3 + 23 2 39(1)X3 
k39(2)X3 [ for X6 "' 461 
S 
Glycogen compartment 
dE for X6 ýý' xI Ef or X4 f 24 
(X23 63 f42(X23 X7 OR X8 > X83 
Tt- "I I 0 (for X6-ý X63 0E for X7 <, X7 ABD 
, 
Py"ruvate COmpartment 
5w 
kXk 
dt 33 3- 53 ý5 + Y'05- k5a X5 
Insulin 
dX6 
at- KIO 
K (x 1) 1-X, 
) Cfor X, > x] 
emogenous insulin dose rate + Z( 
0 Efor X, <, x'] 
dx ax 1: 0] kI(2) (dt 
0Ef or M -;;; Z, 0] ý dt 
fr (X6) 
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Glucagon 
dý 
.a K+ exogenoua glucagon dose rate 0 dt 
Kj(, )(X1- Xll) [for X, > Xjl 
? 
0 [for X 
dX dX 
I >. Ol KJ(2) (7tl) [for rt 
k 
0 Cf or 
dX 
0] 
J(3) X7 
Tt- 
Adrenaline 
.3 or 
`8 - KE. + exogenous adrenaline dose rate + 7-7 a-u Lror &I ?ý lj ) 
-dX dX 1 kE(2) ( Wt-1 ) [f or Tt < 01 
0 [for 
dX 
0 
kE(3) X8 
Tt- 
Details of the non-linear functions, values for rate constants, basal 
secretion rates and physiological threshold values incorporated in the 
model are given in Table I. Y. - 
The method of calculation of these parameters and functions is as followst 
f 12 
(X )ý 
22 
12.0 Gp -- 
p -7 + 1150-0 Gp mol miri7l 
(London 1966). 
- Substrates have the units of molar concentration 
k 80 mg mit71 X. 
1m moi 0.000139 mol mii' 16 2 18 x 3.2 x 10 mg 1- 
1 KE(l) (X, - X, 
) [ for X, e, X, ] 
? 
Efor Xi ilý 
1 
A plasma volume of 3921 is assumed. 
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-1 k 21 = 0-0015 - 7-5 min from graph of glucose-6-phosphatase (Fig-17) 
k. 20.0 mmol ird nm 1177-0 mii' 32 - 17 -0 mmol 
k, 5.0 mmol min 23-1 mini- 23 ý 217 -0 mmol 
ly I M. i miri- I ' 24 "'2' 0-107 
- 
22 + 1848.3 X2 
f 42 
(x 
2) 
13.0 mmol min 200.0 min7l 53 65 -0 )Rmol 
0 mmol miri- 
35 ' 17 -0 )wmol 
(k) n- 
6-95 Ne 
Uu 
k 65 - 0.23 mol miri-1 
1.25 x 
- 0.03 - 31.2 X 
32#0 - 1000.0 X2+ 11*1 
4000.0 X2 + 1.0 
0-000178 +Ne 
2 
m 2950-0 mirý" 
-1 mol min 
-1 mo n 
220. O. Amol min-' k 5a m 65-0,0=01 3 39 miri- 
k1o = 4.0 mU min-' 
k (1) 1.0 mU min7l (4'/100 ml) glucose concentration 
18000.0 mu Mir; -, mol-1 
k1 (2) 2.0 rrIJ miri-1 (mg/100 ml miri-1) 
36000.0 dJ miri-1 (mol miri-1) 
f. 
P1 
Using the experimental glucose and insulin following 
intravenous testing to yield values for insulin level glucose 
elevation and rate of change together with the estimates for 
klot k1 and k 12 substitution in the insulin controller equation 
enabled values of the insulin less function to be obtained as 
listed in Table Ve 
f 12 
(x 
1 w ) 
24 
(X 
2) 0.10722 + 1848.3 X2 
f 42(X2) 
0-03 - 31.2 X2 
11.1 32.0 - 1000.0 X2+ -4000.0 X2 + 1.0 
16 'o 
C5 m 
21 ý 
32 = 
0.000139 mol 
0.23 mol"'M-1 
7-5 mý" 
1177.0 
k 23 23.1 
k 53 200 
k35 2950 
lc5 
a 
3-39 
, mý J ýo 4.0 mU min- 
1 
"EO - 0.9 mg mii' 
kj(1) . 18000 mU miri-' mo171 
kl(2) » 36000 mU mo171 
k (1) . 3600, ffl mir; -' moi-' j 
kJ(2) - 3600ýag mol- 
1 
kJ(3) m o. 625 d-1 
k E(l) 3.6 mg mir; 
-' mol-' 
kE(2) 1.8 
. 
mg mo171 
kE(3) . 2.81 j1 
K Jo 
1.25 X2 
m 0.2 ug min -1 
Xj 0-0045 mol 
xý - 40.0 mU 
lý - 0.48 ug 
xý 0.32 mg 
12-5 X, 
22-7 + 0-3 X, 
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Table IV Details of the non-linear functions, values for rate constants, 
basqL1 secretion rates and physiological threshold values. 
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11 U) f1 (1 (m U/min) 
p Pi p 
0.0 4-P 
86.4 6.3 
112.0 7.3 
128.0 . 15ý7 
150.4 -39.0 
176.0 61 .3 
2.17.6 93.7 
230.6 115-0 
272.0 174.0 
291.0 227.2 
Table V 
k02.0 I/min x 100.0 ng/l 0.2 ug/min j 
1 -1 -1 kjl 1000.0 ug/min mol 
k J2 
kj 3 
k-Eo 
Ei 
w 
1000.0 ua/ p miri-i (Mol miri-1) 
-1 0.625 min 
0.9 mg miri-' 
3.6 izg mir; -' mol-' 
k E2 
kpEl 
m 1.8 mg mii' (mol miri-1) 
m 2.81 mir71 
Threshold values: 
Insulin - 32.0 mU 
Glucagon - 0.48., »g 
Adrenalin - 0.32 mg 
Initial conditions: 
The normal ranges for the steady state are as f ollows 
Glucose 4-0 - 5-5 mmol/& 
Glucose-6-phosphate, 100.0 - 220.0 nmol/g liver 
93 
Triose phosphate 
Glycogen 
Pyruvate 
Insulin 
Glucagon 
Adrenalin 
2-5 - 5.0 r=ol/g liver 
250rol/ml liver 
30-0 - 200.0 nmol/g liver 
5-0 - 15-0ý0/ml 
75-0 - 150-0/g/ml 
0.0 1-0.1 11g1ml 
Assuming a liver mass of 1-5 kg arxl a plasma volume of 3.21 values within 
these ranges were chosen, compatible with a steady state solution of the 
model viz. 
Glucose 
Glucose-6-phosphate 
Triose phosphate 
Glycogen 
Pyruvate 
Insulin 
Glucagon 
Adrenalin 
0-005 mol 
0-0003 mol 
0.000006 moi 
0.25 mol 
0.00122 mol 
= 34.0 mU 
0.32 g 
m 0.16 mg 
Hormone basal secretion rates were calculated from the relationship: 
metabolic clearance rate mean plasma concentration - basal secretion rate. 
The test stimuli were calculated as follows: 
Intravenous plucose injection 
0-59 glUcose/kg body weight is administered over a period of 2 minutes. 
Assuming a mass of 70 kg body weight this represents the administration of 
35/180 moles Of glucose over this period. 
- 
- 
. 11. The dose - 0.0304 mol miri-i 
Primed glucose infusion 
A priming impulse of 15 cm3 of a 0-5 g/ml glucose solution is applied 
over the first 3 minutes of the infusion. Thereafter the glucose solution 
is infused at the rate of 30 ml hr-I 
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. 
.S Dose rate - 0.00435 mol miri-1 (0-3 min) 
= 0.000434 mol mir; - 
I (from then on) 
Intravenous insulin injection 
0.1 U insulin/kg body weight is administered over a period of 1 minute. 
o6o Dose rate - 7000-0 mU mir, 7-1 
At this stage it was realised after preliminary computer runs that the 
model was going to provide problems of computer simulation arising from the 
stiff nature of the set of differential equations. It was observed in 
these preliminary runs that contrary to expectation thob phosphate and 
pyruvate were not dominating substrates. In the simulations their 
dynamics were transient arxi disappeared very rapidly before regaining the 
steady state. This seemed adequate grounds for removal of these parameters 
from the equation set reducing the stiffness. This reduced model was 
subsequently used f or all the, -: work described, though three other features 
were included to improve physiological likeness. 
J) The model was modified to incorporate a speuific switching effect 
either for glycogen synthesis from glucose-6-phosphate or for the latter 
metabolism via the glycolytic pathway depending upon whether glycogen 
storage was saturated or not., This saturation concentration was set at 
0-5 mol, a value twice that of the initial condition. 
ii) Glucagon control of the glucose- 6-phosphate to glycogen sequence was 
also introduced so that when glucagon is elevated above a threshold value 
this sequence is inhibited; a situation only resolved when glucagon falls 
below the critical level. Such a step was necessary to prevent substrate 
recycling through the sequence: 
glucose-6-phosphate . to, UDPG -:, > glycogen glucose-6-phosphate. 
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iii) It was further realised that for realistic simulation of blood 
glucose dynamics account had to be taken of glucose transport into 
peripheral tissues. It was assumed that approximately 20% - 25% of the 
uptake of glucose would be accounted for by peripheral uptake. Membrane 
transport mechanisms involved are regulated by insulin and it is necessary 
for a minimal insulin level to be attained for initiation of the process of 
uptake., However, it is suggested that over a wide range of insulin values 
upwards from this level transport will be controlled by the enzyme dynamics 
of hexokinase. Insulin then adopts a permissive role. 
The rate of production of glticose-6-phosphate is glucose concentration 
dependent as depicted in Figure 17. The hyperbolic slope of the curve 
shows the asymptotic approach to maximal production rate of glucose-6- 
phosphate as glucose concentration tends towards infinity. The dynamics of 
the reaction are similar for both glucokinase and hexokinase catalysed 
reactions the maximum velocity being different. 
The insulin transport effect is effectively modelled by a multiplier 
function. That is 'effective' glucose concentration is multiplied by a 
factor proportional to insulin elevation above the high threshold thus 
moving the reaction towards its maximal velocity. 
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glucose-6-phosphate 
mol/l 
0.001 r 
0.0005 
0.01 
glucose mol/1 
0.02 
Finure 17 
Graph chowing the dependence of the rate of production of 
glucose-6-phosphate upon glucose concentration* 
0.025 ý 
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CHAPTER'6 
TESTING THE MODEL 
The mathematical model was implemented and tested using the CDC 66oo 
and later the CDC 7600 computer at the University of London Computer 
Centre. The programs for this purpose were initially written in the 
digital simulation language MIMIC but were subsequently re-written in 
FORTRAN because of deletion of MIMIC from the compiler. This step would 
have been necessary in any case in an attempt to economise on computer 
time. The program and its sub-routines are presented in facsimiles of 
the computer print-outs on pages 98 to 101 - The integration sub-routine 
involved the use of a fourth-order variable step Runge-Kutta technique. 
The model was subjected to a series of impulses test, representing 
intravenour glucose infusion, the intravenous glucose tolerance testg 
intravenous injection of insulin and injection of glucagon. The model was 
then progressively modified until acceptable simulations were obtained 
either, by adding further equations or by choosing different parameter 
values. A full list of the modifications is given in Table VI. 
A section of a typical computer output is shown in a facsimile of the 
print-out on page 105 
I 
98 
216/0/73 U'lliERSITY OF MItNFSOTA 7620 FIRTRI ,N COMPILEIZ SCOVIt VZoD rSRiC 20*49. JS 
0301033 1. PA0G; -ZA" GNON CINPUTv OUTPUT 9 TAPEltINDUT T iPF2=OUTrUT) sea 1* NOTE - PROGPAn STATEME11T IS, NON ZTMOARD 
-C GLUCWýZ HO: )--L Sj 0501423 26 Cr, 4, jrj If( IS I #NT,. DT, IT mrmpa a) FtnF OC, Flrp, F2lPvFTfPLq 
I FIC: ), FZFP 
0301421) 34 Pj all( 1, ICC) ýl 
- .--, - -C- --- -N 3 U. 0» V. ZPI A U-ES 14 MCEL - OJ 014713 
- 44' 103 rcRMATCIZ) 
- --- - C- - ----X (I) r-r-P PX Q) XMC p X(3) It LO, X C 4) a ZP, X (5) vjP, X(6) rEO, - -- - ýý ---, Rrao(ittoo DTI#TM%Y#T'41N 
TART T14E f)YlzlrllT. INTIGR* STEP9 TMAX v FINAL-T14E, TMI14 vS 
031,1568 6 40 FP-7#4AT(3FiC. fi) 
COCIS61 -- 4p 6^1 3 0,101r, cl -- 9* rZTMIN -ý ciol6t, 3 10* TWRTTw3. 
(03 c I'S ZA ll* QTsrOTI 
010 115-43 4.2v P'-AD(IpIDZ) IX(T)tlzl#N) 
3000ra 
- -1 134 -- . 102 
Ff)RMAT((-Fl3*F. ) ,--ý.. --l. 03P1773 1'4 *A r)(*, t 111) 1r (1) 1,1 xl 1,10) 
-C Ptl)*GAIN RELATING GP ELEVATrON TO rp 
C OM-ar-Al'i REOT14G r-O RPT! 7 TC IP 
- c Pfl)=GAIN q-7LATING GP ---LZ'VATrGN TO JP Rr: LAT14G. -GP PATE. TO- JP-. - P(5)21P THRýSHOLD 
P(6)=J" THRESPnLD 
P17)=JP LOSS CATE COPISTANT 
c PMzGAIN RZLATING rP DEPrZSS104 TO. EP 
P(9)=G%IN RrLATYPIG GP PATE To EP 
't4OLD - c P(LO)=EP THRF, 
; ýPTTFF(7.11P) V2'fT). Tvl. ltl) 
a FIC*3t4Xt7HP(7) I? FO; MAT (H'("- 
:i 
I 7HP(4) wz FID. 3v4Xt7HP(S) r IFIU-59'19 
2 704P(7) gPifl. J//7HPC$) z-qFiC. 3v4Xp7H"(9) = vF10,30"P 
3 PHP(LO) 9FIC93) 
I alp W-ITE(2,103) T, X(lJqX(2), X(3), X(4)pX(5)jY(S) 
? 34 11 13# 1CI rORA0AT(lHDj4HT z IPE13.6, IY, SH rP p IPF-ilo 'I I 
FH mc 
i---- I CH LO pipEll. 3,6H -- IP IPEII. 3, hH JP , Prtt. 
3t6H ýP t 
z tpEltsV) 
03CZ343 23, GO TO 106 
aaCT UR 214 Sol VaT-TtIRIT 
030236e -22# JF(TT. GC. 0*i. A? 40*T. LE. 1V. )-GO TO 114 
WZ421 2.1* IFITT#GF*IeD*lfln*T. GT. 10#) Gn TO 104 
33024Zý3 24* GO TO 118 
0ac2%69 250 104 W*jTr12,105) Tq V (I) X(2) p YM 9Y(4) X(5) v X(S) POX (1) 90)ý 
.. 
nX(4), OX(S), DX(6), F^09FDCtFIIP, F21P, Fr, 
MC ,-14. 
"L 
COV2763 26* 105 FORMAT(lHQv4H. T = iPE13.6, IXI; H Grl , IP--- tie 3 
-1 FH LI) - 91PEII. 3,64 IP 10c I I* . 7o 6H J r, 91V, EI 10 5f"" .--9 
P ipFii., t/? iy. rwnrp tPrti. 3. FH DMr APIý11.3,614 DLO PIPE11031 
tXOSH FCD - -- -- -- -3 AH 010 - IPFII, 3, SH OJO-- tIPE11*3#6H 01-'* slP--11*3/2 
4 IOE11*104 FOC qiDEII*3q6HFITP IPEII. 3,6Hr2lP 
5 f: - 4 Fl -#IPEll#3j6H T Pl, --olPF11*3/1- 
C002763 27* Tw: t! T=T 
a] C? 763 284 -- Jos TF(T. LT. CC, 8) DTxnTl-- 
aa ci Np 1 29 * IF(T. G. E. CM nT=. Gi 
oUlara - CALL 14TEG-1 
0303101 31* IF(T. LT, TMAX) GO TO 107 
4303123 326- - STOP 
Pi gure, 18 
of hepatic The Fortran program used for simulation glucose 
model 
incorporating the master cegment of the Run, 90-Kutta rub-routine 
and the model sub-routines* 
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001375a - Sle 03137513 - s2* 0313751 339 
2 
03137SR 
03137ps 
0313778 
03110003 
03116311 
aI 14CS-3 
01 It# c6cl 
CO 16 174 
0014233 
0314313 
a3 116301 
0014429 
-CO145OR 
CQ 14611 
0114623 
00 l4b7a 
C3 14751 
03 14763 
C314773 
0015013 
0015031 
30 ISC6R 
oa 156fis 
OG15123 
001501 
3J15154 
0015153 
001521a 
ecli 2tri 
003531-3 
00151013 
-c 
q5. 
it. 
SUBROUTINE MODEL 
REAL IIVtJZV 
CO, '1? 1018 X (15) 9DX (IS) IN IT 90T qDT MINI P (10 ) qFCV, FOCI FijPqr2lP9F'L9PLq 
FIL"tF2EP 
NO INPUT 
--- GIV=Q. 17 Vw 1. 
JI V al. 
ETVxC. 
810 Mat. 
quo IF tX (4) . GT. 4! s3t ANle X (4) oLE. 700 .) PLZ 2* 5 *X 9 t) /t 22 o '1+ 115 
00 *X( 1) ) 
9 llp IF Xt 94 ). GTe 7GC. .) XOs Xt1)4Xt1)0tXt4) -70 3e ) 
929- IF Y (4) , GT. 706. ) PL= 2.5 "XPt 92o 7+115 3- *X P) 
9319 nx 11) x r. 1 V-o 300t 19+ ?. r, 4X92) Fc>C- FL 
940 Fr 0=1.2', *X(2) / to 1012? f, 1841%@3*xi 2) 
959 IF 4 X(4) *LT. 0 (! - ). OR. X (3) *GT*09 5) FrOm 0* 
9 F. * 
- 
TFD(, r. t. 33-31 . VOX (2) )1t 32. - iCCO. *X(2) + lie 1/ (43 00 e"l(tZ) *l* 
)) 
CJ ý# I- FDC--TFnC 
qs*. IFIX(! 71. LT. P(C)*AtlloX(S)*LTePtIC)) FOCcOs 
1000 UV(3)=rCn-FOC - 
1014- 1 rllpzeo 
1024- - Ir(x(l)mGT. Q. 0045) FIIP=X(j)-. 0045 F? IP--Do 
IF(Dy(l)9GT. O. ) F21p-znx (i) 10;, * FlfPxC. 
136* IF(Xfi)*LT*C*OJ%5) FIEPz*0045-X(l) 
107* F2SPxg. % 
lo" IF(OX(l)oLTsGe) F2-! 'Pz-0)(CI) 
10" XqU3zY(4) 
1106 CALL FIN!; (XSUngFI) 
ill* X (4 1 jrXSUR 
ill" OX44) ztp. +TTV*P(l)"'FiIP+P(2)*F2TP-FI 
3Y(b)vDoq+Z. IV4P(8)*FlEP+P (q) *F2EP-5.620)f (6) 
Ofilco503 1i5v iýf Tt IQ N 
fin I i;; r,: PrA I 164 Ell! ) 
SE f) 116* CO4MF7NT -1 WORCS USZ2'D IN S; TUP OF SUSCýROGRAM 
NUMBER AND PIA4E CIOSS REFERENCE 41PV lNzQV)EATCD ýl TIMFS 
NA4E TYPE MAIN USE ADMSS PLOCK uxusEng S=STnREOP OTOECLARSOt rzoo IPIC-EXt ScASSIGN, 
ox R ARRAY 03ý01? p // 115S 114S 113S 109U/2 JC4U/? 191S 100S 94S 83D 
EIV R VARIME 0316150 
FCO R VARIAnLE 030OF4R 
FOC R VAPIA3Lý* 03 a G!. Sa 
FI R VAR119E 0100609 
FINS R EXTEROL 
FPC R VARIAILE' 09160P 
FIEP q VARUaLC 003C623 
FlIP R VAQIAqLE 013CF6R 
FZEP q VARIARLE "M jjk. 313 
F2IP q VARIA3LE- 000011; 70 
GIV R VARJAaLE 0116139 
liv q VARIAIV 031375.1 
JIV 4 VAQIAqLF 0013760 
p .1 AIRAY cloc"o 
PL :ý V4RZAILE 03 . V; it. ý 
TFDZ R VAPIA9L-- 00 14ý 14 1 
x4 AIRAY ca 090 art fl 
114U 88a 
IDOU qqU 95S/2 63D 
IGOU 991) 93S/2 S30- - 
117U ilOU 430 
lieu 
, qS :3qU cj. -q Up 
114U ICSS/2 430 - 
ItIU Il? U 10? S/2 830 
114U 165S/2 i3n 
113U tI? U t04S/2 83n 
93U 85S 
112U R611 820 
113U 47S 5? 0 
114LI/7 it311/3 it2U/2 98U/2 95U 830 
93U 'I? S 90S/:! 430 
q7S q7U 
P=00 PARAMETERv *=N. ULL 
114U 113U INS 109U 106U/2 10: PU/2 90U/? 98U/2 96U/3 95U/2 94U/2 93U ]ZU 91U/4 90U14 . -- 
pigure 18 (cont'd] 
sub-routine MODEL 
- -1 
. 
43 
44 
t-ý 
100 
a3 CIO 64 a 34* 5113ROUTIN7' ltjT---GR 
0064643 RýAL KlpK29K3vK4 - 0304643 366 M01314 X( 15) . CX ( 15) , NqT 90T qDTl, *Ttl#P (10 ) ; rCD, IrDr., FllclF21POF19PL 
-1 FIEP, F2rP -- -- OIC4649 37* ny Hl-'WZI 04 KI (SO ) tKZ (50) K3 (50 9 V4 (50) 9X3 CEO p)(Z (50) 
CLD(50) 
03 C166491 384, - ir Rxfl. fl DI 
031222 nt) 60 TrioN 
09 122il --- 4041, - X lý (1 )r- X (1) ý-- - GJl? z7a - j. 1* . T& aT f1f) I 7YJ A P* --- - 14=n7 
001? 363 4S* CA LL MO r)'L 
O'ý 12403 .- .0 S* - cc 10 1z 11, N- _--- -: ý - -- --- - 03 1? 42,3 -67* 10 X7(1)zX(r) 
O'. 1124-oF3 -- ---439 T=T+C@5*H ow, 12473 4 Q40 nc Po l'rlq? J 0012501 so* Kl(l)xm*DX(I) 
03 *42513 51* 25 
Go 12551 5V CALL MODEL 
cot? 570 530 On 33 Tzlgtj 
0012613 54* KZ(I)zH*nX(j)-. 
0012628 31 X(l)zX7(T)*G*FvK2(r) 
C012653 5V 
- 
CALL 14ODF*L 
OJ 11743 574 LX 4C : r-19N 
00 1Z '12B ----ý 6* -- - -- - K3 (1) 2H"nX( 1) -- -_- ý=-. --- ---- ýý----- OCIP733 59* 43 Y(, &. )xv7m*K3(r) 
Of, '1276n 63' 77T+09 S *H 
C313CC13 bl* CALL monrL 
C3133za 62* CC 2 1=19N 
COIM0 630 KL(r)xH*Dxa) 
aaI 3"5ri -. ,- 
; 1.9 -- --2 X(1)*XZ (T)+(Klt I) +2*0*(K2( I) +K3(r) ) +K4(1))/6. - lF(N3-. EO. I) CO TO 3 DG 4. ". q? oo 6;. * 
00 13? 113 nc 5o I zi, N 
cc 137ZI 67* IF CARS (OLO(I) -W (1) ) *GE. A3S (EqIZ*Y(T) GO TO 3 
SEO 67v CAUT104 VAr%lArLF On ArZfZZAY OLD NOT DEFINFD AT THIS poINr 
G313314 6rl* So CCNrINUE 
COL3343 ---. 
69* GO TO 4---- 
Cc 13350 7G* 5 
0313351 ? 14 IF(H. LT. DTMIN) GO-TO-6 
3JI3401 724 )(1 70 1=1914 
C01.11*23 73* VLna)-x(i) 
0013429 71.4 70 X(I)=YS(I) 
001345t3 75* --- TwTO 
C013468 764 NG=1,90*2 - 
001347-3 77* GO TO F 
nI iArfl'i 784 6 -'014TINIJE 
64444 444 4 4p* *** 414 ** 4 *4* 40 **0* 64 
SF- a 780 C04M! jtT - CONT; IoUE STATEMENT IS 43T 00 TERMINATOR 
C0135i3 79* 4 RETURN 
C013523 804 1: No 
sea 804 C04MENT -I 4ORDS USED IN SETUP OF SU9PRCGRAM 
NUMIER AND 4AIF CROFS RIFFEPENCE MAP9 /NzREPEArED N TlmtS 
NU43ER TYPE ADOIESS SN2STATEMEAT NUIErOt r4zFORMAT NUM8FRv JxJU4Pp 
2 SN 901115A 64L 6211 440 
3 SN 0013353 70L 6IJ 65J 
4 sw cal3ilq 79L 63J 
5 SN 20 17341 77J 44L 
6 SN 001351A 75L 7IJ 
IC SN Ogi242S 47L 4iD 
Figure 18 [cont'd] 
sub-routine IVTEGR 
RxRSAD9 WzWRTTE9 L=LOCATEOp O=OD END, AxASSIGNp-T=TRACE 
.- 
SD . 
62 
101 
C316213 117* su-pourIN: CINS(C, SPL) 
0316213 llfk* 014711110"1 XI(ID), FIC13) 
Go 4.621 t3 IL94 
2 ? qloCt22je2/ 
CZILZII 1204 N, =lo 
SE tl 1119 NOTE - N(itl STANIAif) nATA STAT'-T>M-: -4T 
C3 16463 1211F - ir(C. GC. Yltl)) GO TO OC165if) 1224 C. Xxl (1) 
4016513 - 1736 - --2 J--2 c016521 
0016569 
03165711 
OG loý61 1 
00 16rIt 3 
03 16719 
00 1672P1 
00167413 
OC 16759 
0C16773 
0317061 
0317111 
SEI li! io 
sec 1330 
1246 
125* 
1266 
IZ7* 
17,36 
- 12q* 
. 
1300 
1314 
132* 
133* 
1346 
1J. " 
C041FIlT 
COM'lr-NT 
3 Tý* (C-YI (J) ) fig 594 
4 J*J#i 
TF(J*LT*N) GO 70 3 
2 
*4 94 ** * AF 0******* ** » an, ** *0 4*4*444,94 ***4l* ** ** ** *0 * 6*** e**4, ** 44 
rr- I RFICH) WI (W-FT (4) )1( XT(N)-XI (4) 10(r-V I (m)) 
GO TO 
5 srlzrr(j) 
GO TO 7 
6 LzJ-1 
R! TUI! l 
SNO 
W ARG C SHOUL3 RE SET TO LCCLL VARIAPLE FOO FASTER Su'lFRnGRAM SETUP 
14 40i-OS USED IN SETUP OF SIIIPIOGPAM 
IOJMBER AND NAmr CROSS REFIýRENCC MAP#- /NzRFP---ATZO N TrmEs 
NUM3ER TYPE AnDRESS SNZST. TE? iCNT NU4Sclq F. 4zFORMAT NlJfIPERq J=JIJ4P# Q--PEA! o 
2 SN CSjEk2S 123L 121J 
3 SN 3016r, 33 126J IN-L 
4 S-14 30 16-5 69 125L 124J 
5 SN OC16733 ISCL 124J 
6 SN aCtof60 132L 121-J 
7 SN' * 0017,109 114L 13ij 129J 
NAIE TYPE mAlts U-ý_' AMV, '"S qLocx UzUS70, Sz, TGRýG, D=DECLARED, T=Dn 
cR FAPAW-Tr*, R ýJjsrlB 
Fl q AIRAY 0: 16218 
11 VAPIAPLI: 011633R 
iI VIRTAILC Olt737n 
LI VAO; 
it5ýLE C0174,313 
I VARTAW: Goi? 75A 
I VARIIAILE oll"169 
SRI R PAF. 'tf7TFR rll; (. za 
xi 'I ARPAY 0163-ot! 
BLOK NAMES All LENGTHS 
VARIABLE ANO &PRAY EAM-3 SORTED 
001,5213 Fr 
; 
01633P I 
0017403 L 
Olu i2lill 1? 41) 123S 121U it7l 
t33U/3 130U 12611/3 lIcIS ltq'-l 
tiqU/3 tlqT 
133U/4 1321) VOU/2 126S 
133V/4 1333 1331112 
12RU/4 I? BS t28U12 
17SU/4 t270 126U 121S 
134S 131S 12q. ' It7D 
133U/3 12AU/3 l? 4U 1? ZU 
W214RITE, L7LOCATEn, 
, Icf)f) EN09 A--ASSIGN9 T=TRACE 
INC., Xv A24S3TGmq P%00 PARAMETER, *=NULL 
176U Psu 
i2lu It9s 
124U/2 I? iS 
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Sulý-routine FTNS 
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Run I FPC - 12. * 
P(3) - PW - 1000 
P(5) - 32 
P(6) - 32 
Ip (periph) threshold - 65 
JP(O) - 0.4 
----------------------------------- 
Run 2 FPC - 12. * 
PW - IPM - 1000 
P(5) - 32 
P(6) - 32 
Ip (periph) threshold - 45 
JP(O) = 0.4 
----------------------------------- 
Run 3 FPC - 10. * 
P(3) - PM - 1000 
P(5) - 32 
P(6) - 32 
Ip (periph) threshold = 45 
JP(O) - 0.4 
----------------------------------- 
Run 4 FPC . 10. * 
P(3) - PM - 300 
P(5) - 32 
P(6) - 48 
Ip (periph) threshold - 45 
JP(O) - 0.4 
----------------------------------- 
Run 5 FPC - 10. * 
PW - P(4) 100 
P(5) - 32 
P(6) - 48 
Ip (periph) threshold - 45 
JP(O) - . 32 
----------------------------------- 
Run 6 FPC = 8. * 
P(3) - PW 30 
P(5) - 32 
P(6) - 48 
Ip (periph) threshold - 45 
JP(O) - . 32 
----------------------------------- 
Run 7 FPC - 9. * 
PW - PM 30 
P(5) - 32 
P(6) - 48 
Ip (periph) threshold - 45 
JP(O) - . 32 
----------------------------------- 
Run 
As Run 7 except t if 45 IP 700 , PL 
1-5 Gp 
22 7+ 1150 Gp 
if IP ' 700 PL 
1. 
-5* 
[(IP-700)/100+11 
+ Gp 
22-7+1150 IP-7 00 +I Gp 300 
TABLE VI, Progressive modifications to the original mathematical model- 
[cont'd] 
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Run 9 
As run 8 except if IP 700 PL 
1-5 *[(IP-70C))'150tl3 * Gp 
22.7 + 1150 
IP-700 
+1] Gp 150 
Run 10 
1-5*[(! P-700 +1 
Gp 
As run 9 except if IP 700 PL . 50 
22.7 + 1150 * EIP-700 +1] Gp 50 
------------------------------------ 
Run 11 1-5*[ IP-700 +1 Gp 10 
As run 10 except if IP 700 PL . 
22.7 + 1150 
IP-70 
+1] Gp 10 
and IN - 7000 if 10 t 11 min (i. e. to allow Ifalsel transient 
to decay and 'true' steady state 
to be reached. 
------------------------------------ 
Run 12 
As run 11 except if IP 700 PL - 
1-5* r(IP-700) +11 Gp 
22-7 + 1150 L(IP-700) +1] Gp 
---------- 
Run 13 
As run 12 except PL - 3.0 * es@# 
FPG - 8. * 
---------- 
------------------------------------ 
R= 14 
As run 12 except PL - 2-5 
Fpc 8. 
------------------------------------ 
R= 15 
As run 12 except PL 295 *see 
FPC 7.8 
------------------------------------ 
Run 16 Addition of adrenalin. equ. 
Glucagon test applied 
16(a) as r= 16 except FPC - 7.7* 
---------- 
Run 17 
GNON run only for 10 t 20 PCD -0 
------------------------------------ 
Run 18 
If JP 48-0 nD .0 
Run 19 
GNON for 10 t 30 FCD .0 
JINJ Jp(O) - 44 
------------------------------------ 
Ccontld] 
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Run 20 
JINJ 3P(O) - 32 JP' 36 
Sensitivities of Adrenalin eqn. increased by one ordet of magnitude 
----------------------------------- 
Run 21 
As run 20 except JP' - -42 
Adrenalin eqn. sensitivities : 180 (level) 90 (rate) 
----------------------------------- 
Run 22 
As run 21 except JP' - -39 
----------------------------------- 
Run 23 (. TINJ only) Jp' . 42 as run 21 except : 
if Jp JpI PL x(I) / (22-7 + 1150 XM) i. e. reduction 
to 4 G, 46 
normal loss rate 
----------------------------------- 
Run 24 
JINJ as run 23 except 
if jp Jp' PL - 2. * x(l) / (22-7 + 1150 x(l)) 
----------------------------------- 
Run 25 
JIIU only as r= 23 except 
if Jp Jpl PL - 1-5 x(l) 
/ (22-7 + 1150 * x(l)) 
----------------------------------- 
Run 26 
JINJ only as run 23 except 
if jp Jpl PL - 1.25 * x(l) 
/ (22-7 + 1150 * x(l)) 
---------------------------------- 
Run 27 
JINJ as run 23 except 
if Jp Jpl PL - 1-4 x(l) 
/ (22-7 + 1150 * x(l)) 
----------------------------------- 
Run 28 
JIIU only as nm 23 excePt 
PL - 1.45 * x(l) 
/ (22-7 + 1150 
----------------------------------- 
Run 29 
JIIU only as r= 23 except 
PL - 1-42 
----------------------------------- 
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CHAPTER 
RESULTS 
On the subsequent pages are depicted in graphical form the 
results of progressive simulations (Figures 20-57)- The conventions 
adopted are as follows : 
Glucose =01/1 
Insulin mU/3.2 1 
Glucagon pg/3.2 1 
Adrenaline mg/3.2 1 
107 
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0.0052 
0-0050 
0.0048 
a III --nlqa O. OCA& 
mol/I 
0.00441 
O. oo494 
'Figure'20--Result of. model-simulation without any input.; 
Conditions. set as', in run 17. 
lo8 
Figure__21 Simulation of intravenous glucose'tolerance test. 
Conditions set as inrun 2. Not acceptable. 
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Figure 22 Simulation of intravenous glucose tolerance test. ', 
Conditions set as in run 6, - Not acce'table. p 
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Figure 2 Simulation, of intravenous-, glucose tolerance, test. 1 
Conditions set as in run'q* '-Not acceptable. 
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Figure 24. Simulation of intravenous-glucose tolerance-test.,, 
- Conditions set as in run-11. Not*acceptable. 
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Figure 25 Simulation of intravenous, glucose'tolerance*-test. 
Conditions set-as in run. -12. -There. 
is a-good_ 
general conformatioaLil'agreement, between the, ý 
simulation and typical'-experimental, cu rves model 
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Figure 26 This depicts an unsuccessful attempt to improve' 
upon the previousmodel by, incorporating. adrenalin., 
However, ther e is an i nherent instability in the 
fasting state., - 
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Figure 27', Simulation of continuous glucose infusion, 
Conditions sWas for-run 3. Not. acceptable. 
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Figure 28 Simulation of continuous glucose infusion. 
Conditions set as for run. 10. 
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Figure 29 An acceptable simulation of the continuous 
infusion of glucose. Conditions set as run 12. 
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Figure 30 An unsuccessful attempt to include adrenalin 
in the previous, model. Howevert the fasting 
plasma glucose concentration, and the infusion 
steady-state are inappropriately high. --- 
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Figure 31 A more successful attempt, to incorporate! 
adrenalin., Conditions set as run 16(a)-I 
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Figure Simulation of insulin injection'. 32 
Set for run I. 'Not acceptable. 
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Figure 33 Simulation, of insulin injection. 
Set for-run 3-, Not-acceptable. 
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Figure-34, Simulationýof insulin. injectioni; 
Set for run 7. -Not acceptable. -, -, 
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Figure 35 Simulation of inrulin, injection. 
1, 
-Set 
for run 9. Not'acce'Ptable. 
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Figure 36 Simulation of insulin injection. 
Set for run 12. General conformation 
acceptable. - 
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Figure 3?, Simulation of-insulin"injectioneýj 
Incorporation-of adrenalin has 
improved the simulation. 'Set for! 
run 16 (a).. 
125 ' 
Tigure 38 Simulation of glucagon injection., 
Set for run 17. ýNot acceptable. 
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Figure ý9 Simulation of glucagon injection*ýI 
ýSet for run 20. Not acceptable. 
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'. Figure 40 Simulation of glucagon-injection. 
ýSet-, for run 18. -Not acceDtableo 
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Figure-44 Simulation of the model response to a glu6ose 
infusion but vith the activity of glucoser6- 
phosphatase reduced by 30% of its normal 
value. Note fasting hypoglycaemia and under- 
shooting before the nev steady-state is gained. 
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Figure 42 Simulation of glucose infusion but with the 
phosphorylase reaction deleted, from the. model. 
Note, thýre-is no change in the fasting-plasma 
glucose-. concen'tration., 
Figure 45 Model response following intravenous glucose 
injection, but with reduction. of glucose-6- 
phosphatase activity. Note the"switching of 
glucose to a new steady-statillevell the 
multiphasic adrenalin response, and the 
threshold level of insulin. 
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Figure 43 ýimulation of the model response to intravenous 
glucose injection following deletion of the 
phosphorylase reaction from the. - model. 
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Figure 46 Model response, following insulin injection ,' 
but, with glucose-6-phosphatase activity reduced 
30%. There is a marked hypoglycaemia with no 
evidence of returning to the fasting concentration. 
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Figure 47 Result of model response to glucagon injection 
when glucose-6-phosphatase activity was reduced J 
3()'Io- N, ote, transient depression of plasma glucose, j 
and switching of insulin to a new, level. 
Figure 48 Model response to glucose infusion when the 
glucagon threshold is varied. Curves 1,21 
and 3 represent threshold valur's " "of 0.209 
0-39 and 0.60 respectively; Loýering the 
threshold results in highs glpcose steady- 
state values, probably by increasing hepatic 
glucose output. 
135 
Figure 49 Model response-00to glucose infusion but vith 
sensitivity of the glucagon cont oller varied. 
Curves 01 1 and 2r pr seltivalupis of ý0,90 
and 10 in the contr: ll: r"equation. 'Therlatter 
value appears to be optimal. Note the rulti- 
phasic adrenalin response. 
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Figure 50 Simulation of model response to glucose injection 
but with the insulin sensitivity element varied 
from the theoretibal optimum (0). 
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Figure 51 The insulin levels'from. the system depicted in,, i 
the previous figure,, '.,. '- 
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Figure 52, Model response to glucagon injection but with 
the insulin sensitivity varied as previously. - 
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CHAnER 8 
DISCUSSION 
In most models of glucose metabolism emphasis has been upon the 
development of block diagrams, derivirig the transfer functions, or other 
mathematical description, for the blocks in the diagram, and then examining 
the closed loop response to various test inputs. These responses were then 
compared with responses in the real system. If the correspondence was not 
adequate mathematical manipulation of the model was often resorted to in 
order to obtain good fit. This all too often meant a sacrifice of 
pbysiological realism for a dubious statistically valid model. 
The present model seems to offer several advantages over this type of 
f ormul at ion. First, unlike many of the previous models in which there was 
an implicit relationship with the physiology, the present model is explicitly 
based on known physiology and biochemistry, especially at the enzyme level. 
Because there is this degree of parallelism between the model and the real 
system (i. e. isomorphism) the model can be used for testing hypotheses 
concerning the system structure and parameter values and pathological states. 
Furthermore, such a model is of value in studying the control mechanisms 
involved at molecular and organ level in some detail. 
Simulation results in response to the 4 tent stimuli were presented in 
the last chapter and it can be seen that good general conformational agreement 
with experimental test data ia achieved. There has been no attempt to 
quantify in statistical terms the differences between experimental and model 
responses. It was considered more important to obtain a model structure and 
parameter values that were physiologically valid. 
As short term control was being studied primarily the model tends to 
focus on the role of the liver and the dominant enzyme systems. At an e arly 
stage an attempt was nade to incorporate parts of the-glycolytic sequence 
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but computer simulation suggested that their effect upon the system 'Was 
not important. It seemed that the relationships of the glucose - glucose-6- 
phosphate - glycogen triangle were dominant. Other features included were 
insulin-glucagon control of glycogen production and glycogen dismutation, and 
the peripheral uptake of glucose. 
Comment on results 
Variation of hepatic hexokinase activity 
The activity of hepatic hexokinase was progressively- reduced. This was 
effected by charging the rate at which hepatic glucose-6-phosphate was 
produced for a given glucose concentration. , 
This would be analogous to the 
situation thought to obtain in diabetes mellitus1when there is an absolute 
insulin deficiency and consequently a reduction in the activity of the 
glucokinase component of the hepatic hexokinases. 
This variation in glucokinase activity leads primarily, to a change in the 
fasting plasma glucose steady-state concentration. For instance a reduction 
of 40% in glucokinase activity leads to a now glucose, steady-state of 0-014M 
(- 252 mg/100 ml). There are corresponding and proportional, changes in the 
circulating concentrations of insulin and glucagon. -,. I -, -- 
In response to the intravenous injection of insulin the oscillations 
observed in the glucagon response under normal conditions are gradually 
removed as the activity of glucokinase progressively decreasee. 
Following a primed infusion of glucose when the glucokinase activity is 
very low a biphasin insulin response is obtained The 
I, 
phases of this response correspond to the absolute elevation and the rate of 
change of glucose concentration of the priming dose and the constant infusion 
respectively. 
This observation must call into question the views by various authors 
(e. g. Grodsky et al. 1972) concerning the physiological mechanisms involved 
in the pancreatic response leading to biphasic and multiphasic insulin 
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responses. It would appear that such responses could simply reflect the 
pattern of plasma glucose elevation and the rate of change of glucose 
concentration to which the pancreatic P-cells are responding. These 
patterns may alter as a result of differing physiological and pathological 
situations. These observations lead to the hypothesis that the derangements 
of pancreatic metabolism are secondary to extra-pancreatic changes, rather 
than the reverse. If this be the case the pancreatic response is correctly 
reflected by the insulin controller equation. The model also confirms that 
variation of glucokinase activity in the liver contributes significantly to 
the development of impaired glucose tolerance and to the rise in the fasting 
plasma glucose concentration as in diabetes. a 
The activity at the 20% level would be approximately that contributed by 
the haptic glucokinase which is the carbohydrate and insulin independent 
hexokinase. But even at the 80% level of activity (that is 20% diminution 
of activity) the response to inJection of glucagon intravenously is abnormal. 
Instead of a rapid transient hyperglycaemic response, with reattainment of 
the fasting concentration within about 20 minutes, there is a continued 
elevation of glucose (--- This switching of glucose to a 
new steady-state value is the result of glucagon being elevated above its 
threshold value thereby effectively preventing glycogenesisq partly by 
exhibiting the UDP-glucotýt transferase reaction and partly by accelerating 
the phosphorylase reaction. A similar effect can be obtained by altering 
the gain in the mathematical term relating to loss of glucose to the periphery 
or by varying the glucagon threshold level. As a result of this glucose 
switching the levels of insulin and glucagon are also switched. 
The injection of glucose when hepatic hexokinase activity is impaired 
leads to a reduced rate of fall of glucose over the time course of the 
experiment. 
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Variation of peripheral hexokinase activity 
Alteration of peripheral hexokinase activity leads to results rather 
similar to those discussed in the last section though to a markedly lesser 
degree. For instance, a 6W,. 4 reduction in hexokinase activity in peripheral 
tissues brings about a new glucose steady-state concentration of 0.0089M 
(160 mg/100 ml). 
There is a similar lack of glucagon oscillation following the insulin 
sensitivity test and again, glucose switching follows glucagon injection. 
However, this occurs when hexokinase is only slightly impaired. When 
hexokinase activity is down to as little as 40% of normal there is little 
change in the plasma glucose concentration, although there is a slight but 
perceptible shift. 
The observations for both insulin and glucagon suggest that they both 
work through threshold mechanisms. The oscillatory form of the glucose 
response in all runs is also interesting, its association with glucagon 
suggesting the importance of the phosphorylase mechanism in this process. 
In this context it is also interesting that significant variations of plasma 
glucose levels are seen in the early stages of diabetes mellitus and also in 
obesity. There are situations when insulin 'resistance' may enhance 
glucagon 'sensitivity'. 
The phosphorylase reaction 
The phosphorylase reaction was deleted from the model with rather 
interesting results. The effect of removing this-reaction would be to 
prevent mobilisation of hepatic glycogen, a situation, analogous to A'. iglycogen 
storage disease (Type 6 glycogenosis). There wereslight changes 
in the steady-state levels in response to the test stimuli. The new steady- 
state glucose concentration achieved with the primed glucose Infusion was 
reduced to 0-007M (138 mg/100 ml) compared with 0-0084M (151 mg/100 ml) in the 
control situation. 
_ 
Similar changes were observed following intravenous glucose 
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with corresponding changes in hormone steady-state concentrations* There 
was no fall of the fasting glucose concentration in either of these 
situations, and the conformation of the glucose injection and infusion curves 
appear to be normal. Furthermore, the injection of insulin did not yield 
the prolonged hypoglycaemia expected. This suggests that there is another 
mechanism in the gluconeoge4ic pathway, not identified for the purpose of the 
present model, whose activity must vary with, or fall in parallel, with the 
activity of phosphorylase. This is borne out by the fact that the fasting 
steady-state is regained so rapidly after insulin, which can only be due to 
the direct contribution of the gluconeogentic pathway. 
Because, apart from minor iswitching effects, the dynamics of glucose 
are little altered by phosphorylase deletion, it must be concluded that the 
role of gluconeogenesis is concise in the maintenance-of plasma glucose 
homeostasis, and that probably glycogen has only a poorly adapted buffer 
function, and further that glucose uptake is secondary in importance to 
gluconeogenesis in controlling the synthesis of, glycogen. 
The Alucose-6-Dhoanhatase reaction 
The activity of the glucose-6-phosphatase reaction was altered by 
reducing the conversion rate of glucose-6-phosphate to glucose to 30% of its 
normal value. As was expected the fasting glucose concentration fell to 
within the hypoglycaemic range 0.0018M 34 mg/100ml); insulin levels were 
basal. 
Following the primed infusion of glucose a steady-state was attained, 
after urmlershooting, 0.0026M (46 mg/1.60ml). In response to the injection of 
glucose there was a switching of the glucose to a steady-state value of 
0-0013 M (25 mg/100 ml) with a multiphasic adrenaline response. However, 
despite glucose being switched to a lower level value insulin is raised. to a 
level corresponding to its threshold. These observations seem to be of 
concise importance in that they explicitly confirm the role of the liver in 
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regaining the steady-state following perturbation (Soskin and Levine 1938; 
Cramp 1970)- Eurthermore, 9 they provide an insight to the possible 
mechanisms of functional hyperglycaemia in which low glucose concentrations 
together with normal insulin levels are observed following a meal or oral 
glucose loading (Marks and Rose 1965)- 
After insulin injection the plasma glucose concentration remained 
depressed at about 0.001 3M (25 m91100 ml)- Furthermore, the glucagon 
injection caused glucose to be transiently depressed before restoration of 
the steady-state at 0.0019. The latter observation in difficult to explain 
in physiological terms, but both results do highlight the two glucose states 
in which the system is able to switch from one to another under the influence 
of a pulse input. 
Control of the system by insulin 
Apart from the early phase immediately following a stimulus it would 
appear that it is the response to glucose elevation that dominates the 
situation. A change in the sensitivity to glucose elevation alters the 
insulin steady state; a threefold increase in sensitivity raises the 
concentration from 122 mU to 142 mU Following glucose and glucagon stimuli 
a switching of steady-states is observed. The response to insulin itself is 
unchanged but for changes in the insulin steady-state value. These results 
suggest that alteration in the hormone sensitivity element (that is fine 
control) have little effect upon the metabolic processes involved. Threshold 
switching mechanisms appear to dominate for irrespective of changes in 
sensitivity to glucose changes the general confirmation of glucose-insulin 
relationships are unaltered. 
Control of the system by glucagon 
Varying the sensitivity of the glucagon. controller to glucose elevation 
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gives rise to a variety of steady-state switching effects in response to the 
test inputs. However, unlike with insulin, not only the hormonal controllers 
but also the glucose steady-state can be switched. A threefold reduction in 
the glucagon sensitivity leads to a steady-state of 0-007M (126 mg1100 ml) 
following primed glucose infusion, whereas it is 0-, 00517 (90 M&/100 ml) 
following the intravenous injection of glucose. In both situations there 
are multiphaaic adrenaline responses. 
However, following variation of the glucagon threshold level there is 
an alteration of the system steady-state. Reducing the threshold level from 
0-39 to 0.30 ug elevates the glucose steady-state to 0.006M (112 mg/100 ml). 
Changes in the glucagon. threshold level appear to bring about changes in 
steady-state values following perturbation of the system by altering the 
sensitivity of the glycogen - glucose-6-phosphate - glucose reaction sequence. 
Some aspects of control 
The results obtained from the model show that this study has prodwed a 
method for examining closely the variety of control mechanisms that are 
operating upon the metabolism pathways of glucose utilisation. 
It would appear that during the short time scale of the simulations 
coarse control of the system is provided by hormones which are involved in 
threshold effects. Under these circumstances the hormones provide an 
environment in which providing the switching conditions are satisfied the 
appropriate reaction sequences are able to proceed. This would seem to be a 
particularly appropriate situation for use of the term 'permissive'. 
Furthermore, varying the sensitivity of the various hormonal controllers 
to glucose, whilst causing some steady-state changes , 
does not bring about 
significant changes in the conformational. relationships* 
The exception to these latter. considerations would be the action of 
insulin in the periphery at very high concentrations, when a multiplier 
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effect provides an example for direct involvement of the hormone in 
peripheral glucose transport. This may not be surprising as insulin in 
the peripheral tissues is primarily involved in an active membrane transport 
mechanism. The evidence from this study does suggest however that hormones 
provide principally a coarse control mode for glucose metabolism. 
The interactions of insulin and glucagon in an antagonistic manner 
provides an interesting example of what control engineers would call a two 
channel Permissive/inhibitory control. However, what 
is interesting from a 
phylogenetic point of view is the n=ber of hormones that could replace 
glucagon in this two-channel system* Notwithstanding that most of these 
hormones exhibit a variety of metabolic effects the fact that they all 
antagonise insulin action provide a puzzle in redundancyo 
Fine control of glucose appears to reside in small changes of enzyme 
controlled biochemical dynamics. Glucokinase and hexokinase are both examples 
of enzymes in which comparatively small changes in enzyme activity can produce 
substantial changes in the steady-state concentration of glucose. 
Several examples of steady-state switching have been cited that, although 
biochemical phenomena, could be analysed in terms of finite state machine 
behaviour. Indeed, the application of automata theory to biochemical problems 
has received particular attention from Higgins (1963), and it would seem that 
further development is required. 
Application of control theory 
However, the application of the techniques'of control theory to metabolic 
problems at the biochemical level is bedevilled-with problems. There are 
probably two important reasons for this. Pirstly, we are concerned with the 
control properties of very complex systems; complex in the sense that there 
are involved numerous different component sub-systems interacting in a variety 
ýse 
Secondly, there is no established general theory of control of of w, -*r 
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biochemical systems. As succintly stated by Kacser and Burns (1973) - 
"there are bits of theory, but no comprehensive theory. " 
One 'bit' of theory is represented by maps of metabolic Pathways that 
give information on the structure of the system: that is information about 
biochemical transformations, syntheses and degradations. This 'molecular 
anatomy' says 'what goes' but not 'how much'. This area, another 'bit' of 
theory, is covered by enzymology, with its data on individual enzymes, their 
kinetic inhibition and activation characteristics, molecular structure and as 
yet come rudimentary ideas about the theory of catalysis. 
Such discussions that there have been of 'control' and 'regulation' in 
biochemical systems (see for examplecNewsholme and Start 197 3) tend to centre 
on the question of which enzymes are controlling the flux in a pathway metabolic 
and their experimental identification, invariably in vitro,, This identification 
involves measurement of enzyme kinetics and pool sizes, under various 
conditions. Such discussions suggest that controlling enzymes can be 
identified as those that satisfy a number of different criteria (see e. gs, 
Newsholme and Gevers, 1967; Scrutton and Utter 1968; Newsholme and Start 1973) 
which are necessarily related to the measurements. There does seem to be in 
this approach a lack of definition of the various aspects of control to which 
these criteria are applicable. The establishment of necessary and appropriate 
definitions and their relationships needs a rigorous theoretical approach. 
This thesis describes an attempt to provide such an approach, albeit 
elementary, that is based on functional information available in the literature. 
The Purpose of the work was to obtain some insight into control at the sub- 
system level in man which would provide new ideas for experimentq diagnosis 
ard therapy. 
The model does yield information which, for critical reasons, it would be 
difficult to confirm in man, but does corroborate observations made in the 
experimental animal. The Plasmaglucose dynamics certainly reflect in general 
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terms those observed in man following perturbation. It may therefore be 
confidently concluded that the parallelism of the model with the 'real' 
physiological system is good inasmuch as the important control elements have 
been reproduced in the model. It would also appear that assumptions 
concerning the use of kinetic data observed in vitro in predicting the 
physiological characteristics of this particular system in vivo are valid. 
Of course, as is true for all theoretical formulationsp the present 
model, though based on sound assumptions concerning its biochemical and 
physiological structures, may not be the unique model of plasma glucose 
dynamics even though it predicts many recognisable p1iysiological characteristics. 
Nevertheless, it has highlighted the possibility that fine control of plasma 
glucose resides intrinsically within individual enzyme reaction systems rather 
than being dependent solely on circulating hormone levels. This provides an 
avenue that deserves further investigation. 
Conclusions 
A mathematical model has been described that emphasises the importance 
of the fundamental structure of the system and multivariate control. It is 
soundly and explicitly based upon current biochemical and physiological 
concepts, This makes possiblo the investigation of both normal and abnormal 
glucose metabolism and their control processes. The physiologist is provided 
with a tool for testing hypotheses concerning metabolic systems behaviour, and 
obtaining insight into the functioning of the system at various levels. 
Two levels of short term control have been identified within the glucose 
system; hormonal elements appear to provide a coarse control whilst enzymes 
appear to provide the fine control and autoregulatory effects. It does 
appear that hormones primarily maintain the biochemical environment of the 
organism whilst the control of flux within metabolic sequences is intrinsic to 
certain enzymes within the system. 
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APPENDIX I 
THE MICHAELIS-MENTEN KINETIC MODEL AND THE 
BRIGGS-HALDANE MODIFICATION 
The mathematical basis for the kinetics of the fundamental catalytic 
process of enzymology was established in the classical paper of Michaelis 
and Menten (1913)- Their starting point was the following stepwise 
mechanism for explaining the conversion of a substrate S to product P 
by the enzyme Ei 
.E+S 
IL 
ES (Association) (Rapid) A. 1.1 
ES + 
2_ E+ S (Dissociation) (Rapid) () A-1.2 
ES 3- E+P (Decomposition)(Slow) A. I. 3 
Where k,, k2 and k. 3 are the deterministic rate constants of the 
corresponding reaction steps. Thus it was postulated that a molecule of 
enzyme, unlike an inorganic catalyst, actually enters into the reaction 
Process forming an 'enzyme-substrate complex' molecule ES The ES molecules 
are dissociable so that an equilibrium is attained rapidly between the 
reactants E, S and the intermediate species ES * Michaelis and Menten 
postulated that this equilibrium state was not disturbed by occasional 
decompositions of the ES molecules that give rise to-, -the product P and 
the liberated enzyme molecule. The latter is free to complex other substrate 
molecules sequentially; thus is derived the concept of the "turnover number" 
of an enzyme (usually of the order 105mol cmf1se6_1). Reactions of this 
type have a low enzyme requirement in relation to substrate concentration. 
This hypothetical mechanism led to the classical hyperbolic Michaelis- 
Menten equation, relating v, the instantaneous rate of appearance of 
products, with [S] 9 the concentration of substrate present at time t after 
the start of the reaction : 
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v [S] Michael i s-Ment en 
k2+ ESI equation Al 
k 
(equilibrium theory) 
Where V is the maximal value of v. attainable when the total enzyme 
1ý is complexed so that V-k 3Eý * 
This concept of the "equilibrium assumption", that is, the requirement 
that the rate of decomposition of the complex ES into products be slow 
enough so as not to disturb the continuously maintained association- 
dissociation equilibrium was considered by several woxkers to be an over- 
cimplificatione They claimed that the fullest solution could only be 
obtained by solving the complete system of differential equations comprising 
the mathematical model, that is, the differential equation system based on 
the mechanism of Equations AI. I. A1.2 and AJ-3- 
The two independent equations that form the canonical system are : 
iims) 
dt - 
(K 
2+ K3 
) [ES] + KjET ES] - K, [ESIESI AI-5 
,F Si 
-K [ES] - KjET [S] + Kl[ESIESI Al dt 2 
and where ET =E+ ES . 
This system has not been solved completely but a series solution is 
obtainable both for ordinary points and in the neighbourhood of singular 
points (Bartholomy, 1960). 
Briggs and Haldane (1925) replaced the equilibrium assumption of 
Michaelis and Menten with the pseudo-steady-state assumption d(ES)/dt -0 
Using this with equation A1-5 leads to 
v 
VI S] Briggs-Haldane equation Al 
Km +S (steady-state theory) 
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This has the same form as the Michaelis-Menten equation but with 
the generalised Michaelia-Menten constant Km - (K 2+K3 
VK, replacing 
the term K. /K, in the denominator of equation AI-4. 
APPENDIX II 
THE CALCUIATION OP KINETIC COMTAVTS FOR THE PHOSPHORYLASE REACTION 
The rate equation 
(v 
1*K GlPep) - 
(V2*KI3 -GIP) 
V 
KA G6P 
(KP*GlP) + (ýGlp*P) + (KP*GlP) --+I+I 
( 
AMP 
(G-6P 
was derived using the enzymatic mechanisip cited already in Table LI 
Kp and 'GIP are the respective kinetic constants for P1 and glucose-1- 
phosphate; K and KG6P respective dissociation constants for AMP and A 
glucose-6-phosphate. All these constants are independent of substrate, 
activator or inhibitor concentrations* 
In the absence of glucose-6-phosphate and the substrateg glucose-l- 
phosphate say, the above equation reduces to 
v1P 
V- 
(v 
1 -K GIPOP) - 
(V2*KI3 -GIP) 
(A2. I) 
7- (A2,2) 
+X 
I 
PP 'Up/AIMP 
+I This latter expression implies that the with K-K (K 
I 
observed kinetic constant for Pig KP, decreases with the activator ARP 
but that the plot of KI against 1/AMP has a slope Kp9KAMp and intercept p 
KpKp and K A12P are found by this method using 
the data of Helmreich and 
Cori (1964). Equation (A2*2) can further be rearranged 
w 
vI ANP 
AMP p+ KW 
p 
(A2.3) 
in which -I Xjjfp 
- (1/P) (K P) 
KAMP This expression implies that KA'Mp the 
observed kinetic constant for AMP decreases with Pi or glucose-i-phosphatel 
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I 
and that a plot of KAJMP against 1/P Kp. KAMp 9 thus leaving Kpf ar 
above KAMp may be obtailned. Using the equations (A2.2) and (A2-3) and 
the Helmreich and Cori (1964) data respective values of KA]Mp Of 3*2 x 10 
4M 
and 3.6 x 104M are obtained. 
If glucose-l-phosphate is the substrate instead of phosphabe 
.K p/G I P) from which K can be equation 
(A2.3) yields K; Mp 
( 
GI "ANP GIP 
calculated from measurements of- K;, p at different glucose- 1-phosphate 
concentrations if K is known. Allp 
In the absence of inorg4nic phosphate equation (A2.1) rearranges to 
give 
v2. AmP 
(GIP + KGIP 
GlP 
whoro 
It 
to AIMP +K AMP 
KK KAMp G6P ANP GIP 
Gli 
KG6P ) 
it 
can be determined from measurements of-. - K made at constant KG6P ANP 
(A2.4) 
glucose-l-phosphate and ANP concentrations because K GIP and 
K AIMP are 
known. 
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ADDENDUM 
In order to clarify certain passages, expand on others, and include 
textual corrections, this addendum is submitted to supplement the 
thesis "The Modelling of Blood Glucose Dynamics in Man" examined on 
11 July 1975. 
P. 16 line 21 
P. 18 ; line 5 
P. 32 line 21 
last word 
P. 34 line 17 
P. 41 line 25 
P. 50 last line 
P. 65 line 1 
P. 70 last line 
para. 2 
P. 84 Section II 
(ii) 
P. 89 last line 
-1- 
CORRECTIONS 
Insert 'that' to read 'a view that was 
Delete 'estimates' insert 'estimations' 
Spelling of 'phlebitis' 
Insert 'and' to read l(EC 3.1.3.9) and of' 
Delete 'with' insert 'will' 
Spelling of 'concomitantly' 
Should read 'equations (1) to (4)' 
Read *injections' not 'injection* 
Delete 'epinephrine' insert 'adrenaline' 
Delete 'and adrenaline' 
Should read '3.2 l' not '3.211 
P. 93 under heading 'Intravenous glucose injlction' nsert 'litre- 
10 
to read '0.0304 mol miný' litre; "t 1 
P. 94 at top of 
page 
P. 97 para. 2 
1 ine 1 
line 2 
P. 149 para. 2 
line 3 
last line 
P. 152 line 12 
P. 153 line 6 
last para. 
line 1 
Insert'litre-l' to read 10.000434 mol min-' litre-l' 
Should read 'series of test impulses; ' 
Spelling of 'intravenous' 
Delete 'concise' insert 'critical' 
Delete Icondise' 
Should read 'provides a puzzle' 
Insert glatterl to read 'This latter area 
Delete 'critical' insert 'ethical' 
2 
Page 43 et. seq. Development of section ongluconeogenesis 
The path of carbon in glycolyiis and glucoueogenesis is depicted 
in Figure S. 1. The two pathways of glycolysis and gluconeogenesis 
are closely related and as gluconeogenesis is opposed by glycolysis 
it is necessary to have mechanisms able to alter the relative rates 
of these two opposing pathways in order to provide predominance of 
one or the other. Consequently, the regulatory processes must be 
concerned with two important aspects of control, namely substrate 
concentration and direction of metabolic flux. 
Krebs (1957) suggested that, possessing detailed knowledge of a 
metabolic pathway, it is possible to predict which enzymes are 
advantageous for metabolic control, and he went on to point out 
possible sites of control in a pathway, namely: 
1. The initial enzymatic step, 
2. Substrate transport. 
3. Enzymes controlling reactions immediately after a 
branch point. 
4. Enzymes catalysingttwo separate reactions comprising 
the forward and back reaction of one step. 
Thus Newsholme and Gevers (1967) point out that regulatory steps in 
these pathways will be probably found at the following sites: 
1. Membrane transport of the major substrates, namely 
amino acids; pyruvate, lactate, fructose, and glycerol. 
2. Principal metabolic branch pointssrelating to disposal 
of pyruvate, oxaloacetate, phpsphoenolpyruvate, triose 
phosphates, and glucose-6-phosphate. 
3 
3. Enzymes specific for either pathway at undirectional 
sites, namely hexokinase, phosphofructokinase, and 
pyruvate kinase for glycolysis, and pyruvate 
carboxylase, phosphoenolpyruvate carboxykinase, 
fructose-1,6-diphosphatase, and glucose-6-phosphatase 
for gluconeogenesis. 
4. Reactions where nucleotides are cosubstrate such as 
the kinases and glyceraldehyde-3-phosphate 
dehydrogenase. 
The most likely candidates for involvement are pyruvate carboxylase 
and pyruvate dehydrogenase; phosphoenolpyruvate carboxykinase 
(involving malate dehydrogenase, citrate srnthase and aspartate 
iminotransferase);,, Ilpyruvatekkinase and glyceraldehyde-3-phosphate 
dehydrogenase; fructose diphosphatase; phosphofructokinase, 
glucose-6-phosphatase and hexokinase. 
It is in hepatic tissue that the interrelationship between the 
glycolytic and gluconeogenetic pathways appear to be most closely 
subjected to control. 
Control of gluconeogenesis by substrate availability 
The main precursors for glucose formation in the liver are 
glycerol, amino acids, and lactate from glycolysis in extrahepatic 
tissues (Figure S. 1. ). Experiments with the perfused rateliver 
suggest that an increasain the plasma concentration of any of these 
precursors could result in a stimulation of gluconeogenesis, (for 
reviews see Exton, 1972; Exton et al., 11973). For example, the 
half-maximal rate of gluconeogenesis from glycerol is obtained at a 
concentration of 0.5 mM: the plasma level of glycerol in the fed 
animal is 0.1 mM and this is doubled during starvation. However, 
- 
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Figure S. 1 The glycolytic and gluconeogenetic pathways of the liver 
5 
increase substrate availability for gluconeogenesis could also 
arise from a stimulation of amino acid transport into the liver cell. 
There is some evidence that this transport process is modified 
by hormones: for example, glucagon stimulates the transport of alanine 
into the liver cell. It is not known if this hormone stimulates the 
transport of all the amino acids but the inward transport oflysine 
and of the non-metabolisable amino acids, a-aminoisobutyrate and 
cycloleucine, are also increased. 
Amino acids which function as precursors for gluconeogenesis are 
obtained from the breakdown of protein in muscle. This catabolism 
is increased due to changes in the circulating concentration of 
glucocorticoids. Lack of insulin will result in a depression of 
protein synthesis, whereas the glucocorticoids stimulate protein 
degradation. The biochemical mechanisms by which proteins are 
degraded are largely unknown and therefore it is not possible to 
propose a plausible theory for the action of glucocorticoids. 
However, the subject of control of protein concentration by effects 
on synthesis and degradation has been well reviewed by Schimke (1969). 
The plasma lactate concentration can increase to very high 
values (20 mM) during vigorous exercide and in lactic acidosis. 
This would undoubtedly stimulate gluconeogenesis, and the liver and 
kidney cortex play an extremely important role in reducing the 
concentration of plasma lactate. However, it seems unlikely that an 
increase in the concentration of lactate alond can lead to increased 
activities of all the gluconeogenic enzymes. Therefore the 
possibility that lactate could produce changes within the liver that 
could stimulate gluconeogenesis has been investigated. Administration 
of lactate to an intact animal raises the content of pyruvate in the 
- 
liver and this should stimulate pyruvate carboxylase. The administration 
of lactate also increases the hepatic content of citrate and this would 
inhibit PFK and hence lead to stimulation of fructose diphosphate 
hydrolysis (Newsholme and Start, 1973). 
Regulation of gluconeogenesis by hormones 
Of recent years a great deal of experimental work has been carried 
out to investigate the effects of hormones on gluconeogenesis both in 
the intact animal and in the isolated perfused liver. Unfortunately, 
it is still not possible to formulate a satisfactory theory of control 
of the gluconeogenic enzymes by hormones. The effects of hormones on 
gluconeogenesis were reviewed by Newsholme and Gevers (1967), since 
when the major developments in this field stem from the work of Exton 
and Park who have used the isolated perfusediliver to study the 
stimulation of gluconeogenesis by glucagon, adrenaline, and 
glucocorticoids and its inhibition by insulin (Exton, 1972; Exton 
et al., 1973). 
(a) Effect of glucagon on gluconeogenesis 
Newsholme and Gevers (1967) suggested that the effects of glucagon 
on gluconeogenesis might be explained by a stimulation of hepatic 
lipolysis and that the resulting increase in fatty acid oxidation 
would lead to elevated concentrations of acetyl-CoA and citrate. 
Gluconeogenesis would be stimulated as described above. However, 
in careful, precise experiments with the perfused liver, Exton and 
co-workers have shown-that the effect of glucagon on gluconeogenesis 
occurs at physiological concentrations of the hormone, whereas the 
effects on lipolysis and ketosis occur at concentrations that are 
higher than physiological. These workers have also shown that only 
very high concentrations of fatty acids are effective in the - 
stimulation-of g-luconeogene-sis. 
- 
Even at-a. c-oncentra-tion--of 
-1-. 
8 
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fatty acids (bound to a physiological concentration of albumin) 
did not cause a stimulation of gluconeogenesis although the rate of 
ketone body formation was increased and thus presumably the content 
of acetyl-CoA was also increased (although it was not measured). 
Exton and Park conclude that the acetyl-CoA effect on pyruvate 
carboxylase is unimportant in the-control of gluconeogenesis and 
that glucagon must stimulate gluconeogenesis by other means. 
(b) Cyclic AMP and gluconeogenesis 
Both glucagon and adrenaline stimulate adenylcyclase in liver 
and increase the content of cyclic AMP. Therefore, the stimulatory 
effect of these hormones upon gluconeogenesis may be exerted through 
an increase in the concentration of cyclic AMP. The evidence in 
support of this is: the effect of glucagon upon gluconeogenesis is 
very rapid; stimulation of 
14 
C incorporation from [14C] lactate into 
glucose being detectable within 40 seconds of addition of glucagon 
to the perfused liver. The concentration of glucagon that stimulates 
gluconeogenesis half-maximally is the same as that which stimulates 
glyconeogenesis half-maximally'And is the same as that which stimulate'*ý s,, 
glycogenolysis and adenylcylase- (i. e. 2x 10- 
10 M) (Exton et'al., 
1972). The addition of cyclic AMP to isolated rat liver perfusate 
stimulates gluconeogenesis (as measured by 
14 
C incorporation from 
[14C] lactate into glucose) (Exton et al., 1973). 
The effects of glucagon, cyclic ýLMP, and adrenaline on the 
contents of gluconeogenic intermediates in the perfused liver are 
very similar. In particular, a 'cross-over' is observed between 
pyruvate and phosphoenolpyruvate (i. e. pyruvate concentration is 
decreased and phosphoenolpyruvate concentration increased). Thus 
8 
the hormones (and therefore also cyclic AMP) increase the conversion 
of pyruvate to phosphoenolpyruvate. Exton et al. (1972) rule out 
the possibility that this is due to an inhibition of pyruvate kinase 
(and an increase in phosphoenolpyruvate formation due to a substrate 
cycle) by demonstrating that glucagon has no effect on the conversion 
of fructose or dihydroxyacetone to lactate. Therefore, it can be 
concluded that cyclic AMP increases the activity of either pyruvate 
carboxylase or phosphoenol pyruvate carboxykinase (or both)., Further 
experiments involving the incorporation of 
14 
C from [14C] pyruvate 
into malate and phosphoenolpyruvate have suggested that phosphoenol 
pyruvate carboxykinase is the enzyme whose activity is modified by 
glucagon (Exton et al., 1971). Unfortunately, there is virtually no 
evidence that cyclic AMP affects the activity or therproperties of 
the enzyme in vitro. 
(c) Effect of insulin on gluconeogenesis 
Addition of insulin to the perfused liver results in inhibition 
of gluconeogenesis (and glycogenolysis). Whereas, treatment of rats 
with insulin antiserum increases gluconeogenesis and glycogenolysis. 
The administration of insulin antiserum, to rats increases the content 
of cyclic AMP in the perfused liver and this is counteracted by the 
addition of insulin to the perfusate. However, addition of insulin 
to the perfusate when there is no antiserum treatment leads to a 
small decrease in the content of cyclic AMP. Furthermore, insulin 
inhibits the stimulatory effdct of glucagon on gluconeogenesis (and 
glycogenolysis) in the liver and it prevents the rise in cyclic AMP 
content that is observed in the presence of glucagon alone (Exton 
9 
et al., 1973). Hence the physiological effects of insulin on the 
liver, like those of adrenaline and glucagon, may involve changes 
in the concentration of cyclic AMP. 
However, recently Matsuura, Cheng and Kalant (1975) have 
presented evidence that in the rabbit glucose-6-phosphatase is the 
control point for hepatic glucose production and that its activity 
is controlled by insulin which acts as an inhibitor. These 
observations were the opposite of those obtained in the rat in which 
insulin produced a transient rise in glucose-6-phosphatase activity. 
So it is probable that significant species variation occurs. 
(d) Effect of glucagon; insulin ratios on hepatic gluconeogenesis 
Even though insulin and glucagon have antagonistic effects on 
hepatic gluconeogenesis, it is still not clear whether or not the 
hormones are competitive antagonists. As mentioned above, many of 
the glucagon effects appear to be mediated by increasing hepatic 
concentration of cyclic-3', 51-AMP while insulin opposes this process 
by interfering with the action, production or degradation of the 
cyclic-3', 5'-AMP. I 
In vivo insulin and glucagon are simultaneously conveyed to the 
liver from the pancreas via the portal vein, and it is probable that 
the glucagon: insulin ratio in the portal vein may be cardinal in 
controlling hepatic glucose metabolism. Unger (1971) reviewed the 
alterations of glucagon: insulin ratio in various physiological and 
pathological states and suggested that the ratio may be of 
importance in determining the catabolic or anabolic state of the 
liver. However, in a recent paper (Parrilla, Goodman and Toews, 
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, 1974), evidence was presented suggesting 
that the ratio affected 
essentially hepatic glycogenolysis and that gluconeogenesis was 
stimulated only when the glucagon: insulin ratio was probably 
unphysiologically high in the portal vein. 
(e) Effect of glucocorticoids on gluconeogenesis 
Glucocorticoids increase the rate of gluconeogenesis by a 
mechanism which is at present unclear. In the rat, adrenalectomy 
markedly decreases the rate of 
14 
C incorporation into glucose from 
1 14 C] lactate in perfused livers from fasted or diabetic animals. 
However, there is no effect upon the perfused livers taken from fed 
animals. Administration of cortisol to diabetic animals before 
sacrifice improves the incorporation of 
14 
C into glucose in the 
perfused liver. Analysis of the intermediates of gluconeogenesis 
shows that adrenalectomy decreases the rate of pyruvate conversion 
tD phosphoenolpyruvate (Exton et al., 1973). The mechanism is unknown 
but possibly the glucocorticoids play a 'permissive. role', which 
somehow increases the response of the gluconeogenic pathway to cyclic 
AMP. Glucagon is ineffective in activating gluconeogenesis in liver 
from fasted, adrenalectomised rats, but the response to glucagon is 
restored if dexamethasone is added in vitro or in vivo. Since 
adrenalectomy does not interfere with the ability of glucagon to 
increase the content of cyclic AMP in the liver, corticosteroids may 
influence the reaction between cyclic AMP and the gluconeogenic 
enzyme whose activity is modified by gLucagon. The precise 
identification of this enzyme and some knowledge of how it is 
modified by cyclic AMP will doubtless aid the understanding of 
the action of both glucagon and glueocorticoids on gluconeogenesis. 
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The influence of the adrenal cortex on carbohydrate metabolism 
has been well documented since Hartmann and Brownell (1934) 
demonstrated in the dog that the severity of pancreatic diabetes was 
ameliorated by total adrenalectomy while the hypoglycaemic 
response to insulin was increased. This association between 
adrenalectomy and hypoglycaemia had been recognised by Bierry and 
Malloizel in 1908, and was only confirmed by Long and Lukens (1936) 
although the latter paper is better known. The reverse effect, the 
production of steroid diabetes due to glucocorticoid excess is as 
well recognised (Ingle, 1941). 
The metabolic effects of glucocorticoids are opposed by insulin 
(Ashmore, 1964) and in the regulation of carbohydrate, lipid, and 
protein metabolism, these hormones play a key role, for insulin 
increases peripheral glucose utilisation, inhibits peripheral lipid 
mobilisation and modifies extra-hepatic protein synthesis, whilst, 
in the liver, the hormonal roles are reversed; glucocorticoid 
stimulates the de novo enzyme and protein synthesis while insulin 
acts as an inhibitor. The interplay of insulin and corticosteroids 
in the regulation of hepatic enzyme synthesis is of great importance 
(Weber, Singbal and Srivastava, 1965). 
The hepatic effects of the glucocorticoids involve concurrent 
action in peripheral tissues, for the steroids release gluconeogenic 
amino acids from muscle and glycerol and lactate from adipose tissue. 
These precursors are carried to the liver through the blood stream 
and by saturating the hepatic gluconeogenic enzyme systems, contribute 
towards the formation of new hexose molecules. Further, the steroids 
release non-esterified fatty acids (NEFA) which act as the signal 
molecules to the switching mechanism that brings about glucose 
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production. The intra-hepatic metabolism of NEFA also increases the 
acyl-CoA level which activates pyruvate carboxylase. Further, these 
free fatty acids provide the reducing equivalents which promote an 
increase in the level of NADH, which inhibits pyruvate kinase and 
phosphofructokinase. The increased level of gluconeogenic metabolites 
also stabilises the gluconeogenic enzymes by saturating and 
protecting the catalytic centre. These acute actions of the steroids 
are manifest in a few minutes. 
The acceleration of gluconeogenesis by glucocorticoids in 
experimental animals was originally explained in terms of enzymatic 
induction. Several groups of workers, Ray et al. (1964), Greengard 
et al. (1963), Weber et al. (1964), have demonstrated that actinomycin 
D, an RNA synthesis inhibitor, suppresses completely the induced 
elevation of enzymatic activity, but carbohydrate synthesis is only 
partly suppressed. These findings that gluconeogenesis can be 
accelerated independently of de uovo hepatic enzyme synthesis 
suggested that there is regulation at the level of substrate control, 
that is by substrate supply. 
In rats, as shown by Smith and Long (1967) an increased supply 
of amino acids from the peripheral tissues occurs under the influence 
of corticosteroids, and these authors suggest that this is an 
important factor in the high rates of gluconeogenesis in severe 
diabetes mellitus. Also, Betheil et al. (1964) showed significant 
changes in the plasma of rats treated with steroids, namely an 
increase in glutamate, aspartatev and alanine, of 58%, 25%, and 6%, 
respectively. 
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Although as Krebs (1964) has demonstrated there are many steps 
in intrahepatic metabolism that may be rate-limiting, the key reactions 
that are influenced by the reductive environment of the cell are those 
that are NAD dependent (see Figure S. 1. ). Equilibration of lactate, 
glutamate and a-glycerophosphate with their oxidised partners are 
determined by the NADH/NAD 
+ 
ratio prevailing, an increase in this 
ratio diminishes utilisation of these precursors for gluconeogenesis 
and the oxidised partners are removed for gluconeogenesis. 
Continuous substrate oxidations that are necessary for 
gluconeogenesis could also significantly challenge the 2-oxoglutarate 
and pyruvate dehydrogenase steps by diminishing the availability of 
NAD +, but what is as important is that the pyruvate dehydrogenase 
reaction is exquisitely sensitive to NADH inhibition causing a 
decrease in the oxidative decarboxylation rate of pyruvate which 
could be carboxylated via the pyruvate carboxylase reactions to 
oxaloacetate. Generation of oxaloacetate by this reaction is a 
major tate-limiting step in gluconeogenesis (Utter and Keech, 1963), 
this substrate oxidation could attenuate the activity of this enzyme 
by diminishing acetyl-CoA concentration, the allosteric activator, 
and at the same time allowing accumulation of pyruvate which would 
equilibrate with lactate. 
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P. 76 Note on paragraph on "Enzyme Mechanisms" 
Enzyme reaction rates have been specified in terms of 
results obtained from in vitro experiments described in the 
literature. Most of the work described has been performed 
using either the rat or the rabbit as the source of e 
experimental material. Whether results obtained from these 
sources can be directly extrapolated to the human situation 
may be open to some doubt. However, there is as yet minimal 
information available to allow detailed kinetic properties 
of the human enzymes to be included in the model, so animal 
results must be used. 
P. 93 Results for insulin and glucagon dynamics were calculated 
from values obtained from the papers of Turner et al., 1971; 
Genuth, 1972; Goodner and Porte, 1972; Unger, 1972. 
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Further Comments on Chapter 7: 'Results' 
Note The glucose value on the ordinate of each graph represents 
glucose concentration in mol/1 not mmol/l. 
The graphs shown in the Results Section are those selected from 
approximately 3000 computer runs involving 29 model simulations 
(see 
pages 102-104). Each simulation model was derived from the original 
mathematical model by progressively varying parameter values in the 
model equations until an acceptable configuration of the glucose 
and hormone response curves was obtained. The simulation models 
were all subjected to three provocative test stimuli, representing 
the intravenous glucose tolerance test, a primed glucose infusion, 
and the intravenous injection of an insulin bolus. However, the 
model simulations numbered 19--to 29 were also subjected to the 
stimulus representing an intravenous glucagon injection. 
Consideration of the figures in the Results Section 
Figure 20 shows the result of a simulation without any input into the 
system in the form of a test stimulus. It can be seen that the model 
allows any 'false' transients to decay and 'true' steady state to be 
obtained. 
Figures 21-26 represent the graphical plots of data obtained for the 
intravenous glucose injection. Those selected represent the results 
obtained by implementing the parameter conditions of simulation 
models 2,6,9,11,25, and 26. There does_appear to be gradual 
improvement towards the configuration normally seen of glucose and 
hormone response curves with progress through models 2,6, and 9, by 
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(a) altering threshold values for hepatic glucagon, which would 
affect hepatic glucose output, and 
(b) introducing a peripheral 
threshold effect for insulin and altering the sensitivity of the 
phosphorylase equation whereby the glucose-6-phosphate pool can 
be 
replenished in response to the new glucagon threshold. An even 
more acceptable curve configuration shown in Figure 25 was obtained 
from the model by altering the gain for the hepatic glucokinase 
reaction. A further attempt to improve the model was not 
successful (Figure 26) the conformation being similar to that of 
Figure 25. 
It proved impossible with the present model to obtain a 
configuration for the intravenous glucose tolerance test curve that 
resembles the curve that is obtained after glucose! -injection 
in the 
normal human subject. In Figure S. 2 can be seen superimposed upon 
the model produced curve (thesis Figure 25) the curve obtained when 
the intravenous glucose tolerance test values from 122 normal subjects 
are analysed and the mean plotted. Also depicted is a similarly 
obtained curve for the insulin response obtained during these tests 
(all data from Cramp, 1970). Using these curves as criteria of 
acceptability for the model produced curves the following observations 
can be made. The ten minute glucose peak is far too high as is the 
glucose utilisation rate (K value; see page 26). The K value for the 
best glucose curves produced by the model was approximately 8.5, 
whereas the mean K value obtained for the intravenous glucose 
tolerance test series mentioned above was 3.1 (Cramp, 1970). In 
other words, the glucose dissimilation rate appears to be two to 
three times faster for the model than it is in the real 
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physiological situation. This 
is to be expected with the very high 
initial glucose values, for the glucose utilisation rate, and 
hence 
the K value, is directly proportional to the initial elevation of 
the glucose concentration. 
It was assumed that approximately 20 % of a glucose load would 
be available to the peripheral tissues while the other 80 % is 
disposed of by splanchnic tissues, and that the amount of glucose 
'escaping' the liver determines the height of the peak of the 
glucose concentration curve. Indeed, that this assumption was valid 
has been confirmed by Wahren et al. (1974) who demonstrated that, 
using a combined hepatic canuulation and isotopic turnover 
techniquet approximately 85 % of a glucose load is detained by the 
liver, while the remaining 15 % is available for utilisation by 
peripheral tissues. It is this glucose released by the liver for 
peripheral utilisation that determines the conformation of the glucose 
tolerance test curve. In the best model (Figure S. 2) the ten minute 
glucose concentration is over twice the value found in the 
physiological situation, which suggests that the liver is releasing 
over 40 % of its load for peripheral utilisation. The insulin 
levels are initially high in proportion to the glucose stimulus. 
The model was formulated on what was thought to be a sound 
enzymological basis, and it was assumed that it was inherent in 
-the kinetics of the glucokinase/glucose-6-phosphatase reactions 
that glucose uptake or release would occur depending upon whether 
the prevailing plasma glucose concentration was high or low. It 
was further assumed that insulin was only involved in the hepatic 
control of glucose turnover by controlling the UDPG-transferase- 
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phosphorylase steps. It does appear 
from the present model that 
insulin could well be implicated directly in the control of 
hepatic 
glucose release, for it seems that an additional regulating step 
is 
required apart from that intrinsic to the enzyme 
kinetics. As was 
mentioned on page 9 Matsuura, Cheng and Kalant 
(1975) have recently 
demonstrated that in the rabbit glucose-6-phosphatase is controlled 
by insulin which acts as an inhibitor. Also, Unger (1972) and 
Parrilla, Goodman and Toews (1974) have suggested that the glucagon: 
insulin ratio may be important in controlling hepatic glucose 
metabolism. A two site control would not be implausible with 
glucagon operating at the phosphorylawstep and insulin at the 
glucose-6-phosphatase step. Thus a possible reason that the present 
model, while incorporating what was felt to be good enzymological 
data, is deficient in that it does not incorporate glucose-6- 
phosphatase control by insulin. 
Further evidence. for this may this may reside in the results 
obtained for the simulation of the insulin injection. 
Figures 32-37 represent the graphical plots of data obtained for the 
intravenous injection-of insulin. Figure 36 shows the simulation 
obtained for model 12 as used for the best I. V. G. T. T. simulation. 
The degree of hypoglycaemia obtained was adequate when compared with 
that obtained in the human subject, however, the return of the plasma 
glucose towards the fasting level is far too rapid and unphysiological. 
Hepatic release of glucose may have been too rapid, but it could be 
possible that had a competitive-Anhibition of glucose-6-phosphatase 
by insulin been incorporated a truly physiological picture would have 
been obtained. 
- 19 - 
Similar conclusions could be reached over the continuous 
infusion of glucose. 
Figures 27-31 show the graphical plots for these infusions. The 
initial peak is again too high (see Figure S. 4) but once a steady- 
state is attained the hepatic autoregulatory mechanisms, probably 
independent of hormonal control, take over. 
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Some Conclusions 
In the mathematical model described the importance of the 
fundamental structure of the biochemical system in enzymological 
terms has been emphasised. In this sense the model was thought to 
be soundly based. However, the critical weakness of the model lay 
in its inability to simulate absolutely the results obtained in 
the real phýological situation. Recent work has highlighted the 
possible importance of insulin as an inhibitor of glucose-6- 
phosphatase and it is felt that incorporation of such a mechanism 
would improve the model and increase its value. 
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Figure S. 2 Simulation of intravenous glucose tolerance test. 
Superimposed 
is the curve 
(in red) upon the best obtainable model produced curves 
obtained from the I-V-G. T. T. glucose and insulin 
values from 122 normal subjects (data from Cramp, 1970). Conditions 
set as run 12 
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Figure S. 3 
. Go2r, 
r-35 
Simulation of insulin injection. Superimposed (in red) 
is the curve obtained from an insulin sensitivity test performed 
upon the author 
I 
Figure S. 4 Simulation of the continuous infusion of glucose. 
Superimposed (in red) is the curve obtained from an infusion 
experiment upon the author. Conditions set as run 12 
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